<SEC-DOCUMENT>0001178913-17-001545.txt : 20170518
<SEC-HEADER>0001178913-17-001545.hdr.sgml : 20170518
<ACCEPTANCE-DATETIME>20170518160944
ACCESSION NUMBER:		0001178913-17-001545
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20170518
FILED AS OF DATE:		20170518
DATE AS OF CHANGE:		20170518

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVA MEASURING INSTRUMENTS LTD
		CENTRAL INDEX KEY:			0001109345
		STANDARD INDUSTRIAL CLASSIFICATION:	OPTICAL INSTRUMENTS & LENSES [3827]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30668
		FILM NUMBER:		17855021

	BUSINESS ADDRESS:	
		STREET 1:		PO BOX 266
		STREET 2:		011-972-8-938-7505
		CITY:			REHOVOT ISRAEL
		STATE:			L3
		ZIP:			76100
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk1719996.htm
<DESCRIPTION>6-K
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.2.1.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br>
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">UNITED STATES</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Washington, DC&#160;20549</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">FORM 6-K</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">REPORT OF FOREIGN PRIVATE ISSUER</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PURSUANT TO RULE 13a-16 OR 15d-16 OF&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">THE SECURITIES EXCHANGE ACT OF 1934</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">For the month of May 2017<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><br style="LINE-HEIGHT: 1.25">
 Commission File No.: 000-30668</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 16pt/1.25 'Times New Roman', Times, serif">NOVA MEASURING INSTRUMENTS LTD.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Translation of registrant&#8217;s name into English)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Building 22 Weizmann Science Park, Rehovot</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">P.O.B 266</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Israel</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;(Address of principal executive offices)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Form 20-F <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Wingdings 2', serif">S<font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font>&#160;Form 40-F <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Wingdings 2', serif">&#163;</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Attached hereto and incorporated by way of reference herein are the following documents:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zc00bc12d464b47bcb622ac184a211efa" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 18pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Registrant&#8217;s Notice of Annual General Meeting of Shareholders and Proxy Statement for its 2017 Annual General Meeting of Shareholders.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="ze645336f5275496691e57c9059e4b790" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 18pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Proxy card for use in connection with the Registrant&#8217;s 2017 Annual General Meeting of Shareholders.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">This report on Form 6-K is hereby incorporated by reference into the Registrant&#8217;s registration statements on Form S-8, filed with the Securities and Exchange Commission on the following dates: November 5, 2007 (File No. 333-147140), October 25, 2012 (File No. 333-184585) and March 6, 2015 (File No. 333-202550).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">SIGNATURES</font>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z36cc8194fbe64b1ea5a13cb2f650f828" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Date: May 18, 2017&#160;</div>
</td>
<td style="WIDTH: 10%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOVA MEASURING INSTRUMENTS LTD.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>(Registrant)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>By: /s/ <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Dror David</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Dror David<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Chief Financial Officer</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Exhibit Index</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">99.1 Notice of Annual General Meeting of Shareholders and Proxy Statement</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">99.2 Proxy Card</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.2.1.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: right; FONT: bold 10pt/1.25 'Times New Roman', Times, serif"><u>Exhibit 99.1</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOVA MEASURING INSTRUMENTS LTD.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Notice is hereby given that the annual general meeting of shareholders (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Meeting</u></font>&#8221;) of Nova Measuring Instruments Ltd. (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Company</u></font>&#8221;) will be held on June 22, 2017, at 5:00 p.m. Israel time (10:00 a.m. Eastern time), at the Company&#8217;s offices, located at Weizmann Science Park, Building 22, Einstein St., Ness Ziona, Israel.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">The agenda of the Meeting shall be as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zb841daf21b874d6c9eb00c8b21004d09" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.6pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Re-election of each of Messrs. Michael Brunstein, Alon Dumanis, Avi Cohen, Raanan Cohen and Eli Fruchter as a director of the Company to hold office until the close of the next annual general meeting;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zdd5a25b515744848a3b7b67540951f61" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.6pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Re-election of Ms. Zehava Simon as an external director of the Company for a three-year term, commencing as of June 24, 2017;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zb09117b1500e435389b5c44af421b055" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.6pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Approval of amendments to the employment terms of Mr. Eitan Oppenhaim, the President and Chief Executive Officer of the Company;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zddeadd0326964131848bfdc92bd11d93" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.6pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Ratification and approval of a framework of terms and conditions for the extension, renewal and entering an </font>insurance<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> policy for directors&#8217; and officers&#8217; liability, subject to, and in accordance with, the provisions of the Companies Law; and</font></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z11f917579b604078a35b67f44776b6c8" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.6pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Approval and ratification of the re-appointment of Kost Forer Gabbay &amp; Kasierer, a member of Ernest &amp; Young, as the independent auditors of the Company for the period ending at the close of the next annual general meeting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 27pt">In addition, the shareholders will be requested to consider at the Meeting the Company&#8217;s audited consolidated financial statements for the year ended December 31, 2016.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">We know of no other matters to be submitted at the Meeting other than as specified herein. If any other business is properly brought before the Meeting, the persons named as proxies may vote in respect thereof in accordance with their best judgment.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">In accordance with the Israeli Companies Law 5759-1999, and regulations promulgated thereunder (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Companies Law</u></font>&#8221;), any shareholder of the Company holding at least one percent of the outstanding voting rights of the Company for the Meeting may submit to the Company a proposed additional agenda item for the Meeting, to the Company&#8217;s offices, c/o Ms. Orly Dean, at Weizmann Science Park, Building 22, Einstein St., Ness Ziona, Israel, no later than Wednesday, May 17, 2017. To the extent that there are any additional agenda items that the Board determines to add as a result of any such submission, the Company will publish an updated agenda and proxy card with respect to the Meeting, no later than Wednesday, May 24, 2017, which will be furnished to the U.S. Securities and Exchange Commission (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Commission</u></font>&#8221;) on Form 6-K,&#160;and will be made available to the public on the Commission&#8217;s website at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.sec.gov</u></font> and in addition at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.magna.isa.gov.il</u></font> or <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://maya.tase.co.il</u></font>.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The approval of each of the Proposals requires the affirmative vote of the Company&#8217;s shareholders holding at least a majority of the Company&#8217;s ordinary shares (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Shares</u></font>&#8221;) present, in person or by proxy, and voting on the matter.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The approval of Proposal No. 2 is also subject to the fulfillment of one of the following additional voting requirements: (i) the majority of the Shares that are voted at the Meeting in favor of the Proposal, excluding abstentions, includes a majority of the votes of shareholders who are not controlling shareholders or do not have a personal interest in the Proposal other than personal interest that is not resulting from relationship with the controlling shareholders; or (ii) the total number of shares of the shareholders mentioned in clause (i) above that are voted against Proposal No. 2 does not exceed two percent (2%) of the total voting rights in the Company.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The approval of Proposal Nos. 3 and 4 is also subject to the fulfillment of one of the following additional voting requirements (such majority, determined in accordance with clause (i) or (ii) below, shall be referred to hereinafter as a &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Special Majority</u></font>&#8221;):</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zc04f748230694ffd9c80f633378aede2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 14.2pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 21.25pt; align: right">(i)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the majority of the Shares that are voted at the Meeting in favor of the Proposal, excluding abstentions, includes a majority of the votes of shareholders who are not controlling shareholders or do not have a personal interest in the Proposal; or</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z3d2d8604a5054111b11d7fb2a1592ba0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 14.2pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 21.25pt; align: right">(ii)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the total number of Shares of the shareholders mentioned in clause (i) above that are voted against the Proposal does not exceed two percent (2%) of the total voting rights in the Company.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">For this purpose, a &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">controlling shareholder</font>&#8221; is any shareholder that has the ability to direct the Company&#8217;s activities (other than by means of being a director or office holder of the Company), including a person who holds 25% or more of the voting rights in the general meeting of the Company if there is no other person who holds more than 50% of the voting rights in the company; for the purpose of a holding, two or more persons holding voting rights in the Company each of which has a personal interest in the approval of the transaction being brought for approval of the company shall be considered to be joint holders. A person is presumed to be a controlling shareholder if it holds or controls, by himself or together with others, one half or more of any one of the &#8220;means of control&#8221; of a company. &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Means of control</font>&#8221; is defined as any one of the following: (i) the right to vote at a general meeting of a company, or (ii) the right to appoint directors of a company or its chief executive officer. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">A </font>&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">personal interest</font>&#8221;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>of a shareholder <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">in an action or transaction of a company includes&#160;a personal interest of any of the </font>shareholder&#8217;s<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> relatives (i.e. spouse, brother or sister, parent, grandparent, child as well as child, brother, sister or parent of such </font>shareholder<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8217;s spouse or the spouse of any of the above) or an interest of a company with respect to which the </font>shareholder<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> or the </font>shareholder<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8217;s relative (as defined above) holds 5% or more of such company&#8217;s issued shares or voting rights, in which any such person has the right to appoint a director or the chief executive officer or in which any such person serves as director or the chief executive officer, including the personal interest of a person voting pursuant to a proxy which the proxy grantor has a personal interest,</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">whether or not the person voting pursuant to such proxy has discretion with regards to the vote; and excludes an interest arising solely from the ownership of ordinary shares of a company.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">I</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">f you do not state whether you are a controlling shareholder or have personal interest your shares will not be voted for Proposal Nos. 2, 3 and 4</font>.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">Only shareholders of record at the close of business on May 15, 2017, (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Record</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>&#160;</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Date</u></font>&#8221;) will be entitled to receive notice of, and to vote at the Meeting. All shareholders are cordially invited to attend the Meeting in person.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">Shareholders who will not attend the Meeting in person may vote with respect to Proposal Nos. 1 through 5 by means of a proxy card and are obliged to complete, sign, date and return the proxy card no later than four hours before the time of the Meeting (i.e., 1:00 p.m. (Israel time) on June 22, 2017). A form of proxy card will be enclosed with the proxy statement. The form of proxy card will be furnished to the Commission on Form 6-K, and will be available to the public on the Commission&#8217;s website at http://www.sec.gov and in addition at http://www.magna.isa.gov.il or http://maya.tase.co.il.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">- 2 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">All Shares represented by properly executed proxies received prior to or at the Meeting and not revoked prior to, or at, the Meeting in accordance with the procedures described in the proxy statement, will be voted as specified in the instructions indicated in such proxies. Subject to applicable law and the rules of The NASDAQ Stock Market, in the absence of such instructions, the Shares represented by properly executed and received proxies will be voted &#8220;FOR&#8221; all of the proposed resolutions to be presented at the Meeting for which the Company&#8217;s board of directors recommends a &#8220;FOR&#8221;, other than Proposal Nos. 2, 3 and 4.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Shareholders wishing to express their position on an agenda item for this Meeting may do so by submitting a written statement (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Position Statement</u></font>&#8221;) to the Company&#8217;s offices, c/o Ms. Orly Dean, at Weizmann Science Park, Building 22, Einstein St., Ness Ziona, Israel. Any Position Statement received will be furnished to the Commission on Form 6-K, and will be made available to the public on the Commission&#8217;s website at http://www.sec.gov and in addition at http://www.magna.isa.gov.il or http://maya.tase.co.il. Position Statements should be submitted to the Company no later than June 12, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">A shareholder is entitled to contact the Company directly and receive the text of the proxy card and any Position Statement.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">A shareholder, whose Shares are registered with a TASE member and are not registered on the Company&#8217;s shareholder&#8217;s register, is entitled to receive from the TASE member who holds the Shares on the shareholder&#8217;s behalf, by e-mail, for no charge, a link to the text of proxy card and to the position statements posted on the Israel Securities Authority website, unless the shareholder notified that he or she is not so interested; provided, that the notice was provided with respect to a particular securities account, prior to the Record Date.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">A shareholder, whose shares are registered with a member of the TASE, is required to prove his or her share ownership to vote at the Meeting. Such shareholder shall provide the Company with an ownership certificate (as of the Record Date) from that TASE member and is entitled to receive the ownership certificate in the branch of the TASE member or by mail to his address (in consideration of mailing fees only), if the shareholder so requested. Such a request will be made in advance for a particular securities account. Alternatively, shareholders who hold shares through members of the TASE may vote electronically via the electronic voting system of the Israel Securities Authority up to six hours before the time fixed for the Meeting. You should receive instructions about electronic voting from the TASE member through which you hold your shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Discussion at the Meeting will be commenced if a quorum is present. A quorum is constituted by two or more shareholders who are present in person or by proxy, or who have delivered to the Company a proxy card indicating their manner of voting, and who hold or represent Shares conferring in the aggregate at least one-third (33.33%) of the voting power in the Company. If a quorum is not present within half an hour of the time designated for the Meeting, the Meeting will be adjourned to Tuesday, June 27, 2017, at the same time and place. At the adjourned Meeting, any number of shareholders who are present in person or proxy, or who have delivered a proxy card, will constitute a quorum.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">- 3 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The wording of the resolutions to be voted at the Meeting and relevant documents thereto may be inspected at the Company&#8217;s offices, which are located at the Company&#8217;s offices at the Weizmann Science Park, Building 22, Einstein St., Ness Ziona, Israel during normal business hours and by prior coordination with Ms. Orly Dean (tel: +972-73-2295621).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z4653376648e94e31a046795618ca69cc" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 60%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 40%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">By Order of the Board of Directors,</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt"><img style="HEIGHT: 37px; WIDTH: 128px" src="image0.jpg"></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 60%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 40%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">Dr. Michael Brunstein,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Chairman of the Board of Directors </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">of the Company<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: May 10, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
 &#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">- 4 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOVA MEASURING INSTRUMENTS LTD.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Weizmann Science Park</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Building 22, Einstein St., Ness Ziona</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Israel</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">_____________________________</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PROXY STATEMENT</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">_____________________________</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">TO BE HELD ON JUNE 22, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">This proxy statement is furnished to the holders of ordinary shares, par value NIS 0.01 per share (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Shares</u></font>&#8221;), of Nova Measuring Instrument Ltd. in connection with the annual general meeting of shareholders of the Company to be held at the Company&#8217;s offices at the Weizmann Science Park, Building 22, Einstein St., Ness Ziona, Israel on June 22, 2017, at 5:00 p.m. Israel time (10:00 a.m. Eastern time), and thereafter as it may be adjourned from time to time (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Meeting</u></font>&#8221;). Unless the context otherwise requires, references in this Proxy Statement to &#8220;Nova,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221; refer to Nova Measuring Instruments Ltd. &#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">At the Meeting, the following resolutions will be proposed for adoption by the shareholders:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z23014fd5d4e84a739b29f8cd54657d1f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.45pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Re-election of each of Messrs. Michael Brunstein, Alon Dumanis, Avi Cohen, Raanan Cohen and Eli Fruchter as a director of the Company to hold office until the close of the next annual general meeting;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z09418dfcc1e24167b34d8acb2003148a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.6pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Re-election of Ms. Zehava Simon as an external director of the Company for a three-year term, commencing as of June 24, 2017;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zd1a78b6f439c496390ca642fe67b8f73" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.6pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Approval of amendments to the employment terms of Mr. Eitan Oppenhaim, the President and Chief Executive Officer of the Company;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z0e5944736da84a4c9a98fa1f75273a99" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.6pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Ratification and approval of&#160; a framework of terms and conditions for the extension, renewal and entering into an </font>insurance<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> policy for directors&#8217; and officers&#8217; liability, subject to, and in accordance with, the provisions of the Companies Law</font>; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zde5afaae266741579f967e6868ab1643" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 17.6pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Approval and ratification of the re-appointment of Kost Forer Gabbay &amp; Kasierer, a member of Ernest &amp; Young, as the independent auditors of the Company for the period ending at the close of the next annual general meeting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">In addition, the shareholders will be requested to consider at the Meeting the Company&#8217;s audited consolidated financial statements for the year ended December 31, 2016.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">Shareholders Entitled to Vote</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Only holders of record of Shares at the close of business on May 15, 2017, (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Record Date</u></font>&#8221;) are entitled to receive notice of, and to vote at, the Meeting.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">As of May 15, 2017, the Company had 27,631,565 issued and outstanding Shares. Each Share is entitled to one vote on each matter to be voted on at the Meeting. The votes of all shareholders voting on a matter are counted and abstentions are not taken into account (other than for quorum purposes).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">Proxies</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">All shareholders who are unable to attend the Meeting in person are requested to complete, date and sign the enclosed form of proxy and return it promptly in the pre-addressed envelope provided.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">If you hold ordinary shares in &#8220;street name,&#8221; that is, you are an underlying beneficial holder who holds ordinary shares through a bank, broker or other nominee, the voting process will be based on your directing the bank, broker or other nominee to vote the ordinary shares in accordance with the voting instructions on your voting instruction card. Because a beneficial owner is not a shareholder of record, you may not vote those shares directly at the Meeting unless you obtain a &#8220;legal proxy&#8221; from the bank, broker or nominee that holds your shares, giving you the right to vote the shares at the Meeting.</div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt">Please follow the instructions on the proxy card or voting instruction card received from your bank, broker or nominee. You may also be able to submit voting instructions to a bank, broker or nominee by phone or via the Internet if your voting instruction card describes such voting methods.&#160;Please be certain to have your control number from your voting instruction card ready for use in providing your voting instructions.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt">It is important for a shareholder that holds ordinary shares through a bank or broker to instruct its bank or broker how to vote its shares if the shareholder wants its shares to count for the proposal.</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">A shareholder, whose shares are registered with a TASE member and are not registered on the Company&#8217;s shareholder&#8217;s register, is entitled to receive from the TASE member who holds the shares on the shareholder&#8217;s behalf, by e-mail, for no charge, a link to the text of proxy card and to the position statements posted on the Israel Securities Authority website, unless the shareholder notified that he or she is not so interested; provided, that the notice was provided with respect to a particular securities account, prior to the Record Date. A shareholder, whose shares are registered with a member of the TASE, is required to prove his or her share ownership to vote at the Meeting. Such shareholder shall provide the Company with an ownership certificate (as of the Record Date) from that TASE member and is entitled to receive the ownership certificate in the branch of the TASE member or by mail to his address (in consideration of mailing fees only), if the shareholder so requested. Such a request will be made in advance for a particular securities account. Alternatively, shareholders who hold shares through members of the TASE may vote electronically via the electronic voting system of the Israel Securities Authority up to six hours before the time fixed for the Meeting. You should receive instructions about electronic voting from the TASE member through which you hold your shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Upon the receipt of a properly executed proxy in the form enclosed herewith, the persons named as proxies therein will vote the Shares covered thereby in accordance with the directions of the shareholder executing such proxy. Subject to applicable law and the rules of The NASDAQ Stock Market, in the absence of such instructions, the Shares represented by properly executed and received proxies will be voted &#8220;FOR&#8221; all of the proposed resolutions to be presented at the Meeting for which the Company&#8217;s board of directors (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Board</u></font>&#8221;) recommends a &#8220;FOR&#8221;, other than Proposal Nos. 2, 3 and 4.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">Position Statements</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Shareholders wishing to express their position on an agenda item for this Meeting may do so by submitting a written statement (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Position Statement</u></font>&#8221;) to the Company&#8217;s offices, c/o Ms. Orly Dean, at Weizmann Science Park, Building 22, Einstein St., Ness Ziona, Israel. Any Position Statement received will be furnished to the Securities and Exchange Commission (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Commission</u></font>&#8221;) on Form 6-K, and will be made available to the public on the Commission&#8217;s website at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.sec.gov</u></font> and in addition at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.magna.isa.gov.il</u></font> or <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://maya.tase.co.il</u></font>. Position Statements should be submitted to the Company no later than June 12, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">2</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Meeting Agenda</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">In accordance with the Israeli Companies Law 5759-1999, and regulations promulgated thereunder (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Companies Law</u></font>&#8221;), any shareholder of the Company holding at least one percent of the outstanding voting rights of the Company for the Meeting may submit to the Company a proposed additional agenda item for the Meeting, to the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Company&#8217;s offices, </font>c/o Ms. Orly Dean, at Weizmann Science Park, Building 22, Einstein St., Ness Ziona, Israel<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">, no later than Wednesday, May 17, 2017</font>. To the extent that there are any additional agenda items that the Board determines to add as a result of any such submission, the Company will publish an updated agenda and proxy card with respect to the Meeting, no later than <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Wednesday, May 24, 2017</font>, which will be furnished to the Commission on Form 6-K,&#160;and will be made available to the public on the Commission&#8217;s website at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.sec.gov</u></font> and in addition at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.magna.isa.gov.il</u></font> or <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://maya.tase.co.il</u></font>.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">Expenses and Solicitation</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The Company expects to solicit proxies by mail and to mail this proxy statement and the accompanying proxy card to shareholders on or about May 23, 2017. This proxy statement and the accompanying proxy card are also available to the public through one the following websites <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.magna.isa.gov.il</u></font>, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://maya.tase.co.il</u></font> or <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.sec.gov</u></font>.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">All costs of solicitation of proxies will be borne by the Company. In addition to solicitations by mail, certain of the Company&#8217;s directors, officers and regular employees, without additional remuneration, may solicit proxies by telephone, telegraph and personal interviews. Brokers, custodians and fiduciaries will be requested to forward proxy soliciting material to the beneficial owners of Shares held in their names, and the Company will reimburse them for their reasonable out-of-pocket costs.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">Quorum and Voting Requirements</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The quorum required consists of two or more shareholders who are present in person or proxy (or who have delivered a proxy card indicating their manner of voting) and who together hold or represent Shares conferring in the aggregate at least one third (33.33%) of the voting power in the Company. If a quorum is not present within one half hour of the time designated for the Meeting, the Meeting shall be adjourned to Tuesday, June 27, 2017, at the same time and place.&#160; At the adjourned Meeting, any number of shareholders who are present in person or by proxy, or who have delivered a proxy card, shall constitute a quorum.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">The approval of each of the Proposals requires the affirmative vote of the Company&#8217;s shareholders holding at least a majority of the Shares present, in person or by proxy, and voting on the matter.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The approval of Proposal No. 2 is also subject to the fulfillment of one of the following additional voting requirements: (i) the majority of the Shares that are voted at the Meeting in favor of the Proposal, excluding abstentions, includes a majority of the votes of shareholders who are not controlling shareholders or do not have a personal interest in the Proposal other than personal interest that is not resulting from relationship with the controlling shareholders; or (ii) the total number of shares of the shareholders mentioned in clause (i) above that are voted against Proposal No. 2 does not exceed two percent (2%) of the total voting rights in the Company.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">3</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The approval of Proposal Nos. 3 and 4 is also subject to the fulfillment of one of the following additional voting requirements (such majority, determined in accordance with clause (i) or (ii) below, shall be referred to hereinafter as a &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Special Majority</u></font>&#8221;):</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z77d3586f744b41afb8eed0b188de72e6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 30.6pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 39.75pt; align: right">(i)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the majority of the Shares that are voted at the Meeting in favor of the Proposal, excluding abstentions, includes a majority of the votes of shareholders who are not controlling shareholders or do not have a personal interest in the Proposal; or</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zc6c693e9aa1d4e7abc92e7352a7fb6ac" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 30.6pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 39.75pt; align: right">(ii)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the total number of Shares of the shareholders mentioned in clause (i) above that are voted against the Proposal does not exceed two percent (2%) of the total voting rights in the Company.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">For this purpose, a &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">controlling shareholder</font>&#8221; is any shareholder that has the ability to direct the Company&#8217;s activities (other than by means of being a director or office holder of the Company), including a person who holds 25% or more of the voting rights in the general meeting of the Company if there is no other person who holds more than 50% of the voting rights in the company; for the purpose of a holding, two or more persons holding voting rights in the Company each of which has a personal interest in the approval of the transaction being brought for approval of the company shall be considered to be joint holders. A person is presumed to be a controlling shareholder if it holds or controls, by himself or together with others, one half or more of any one of the &#8220;means of control&#8221; of a company. &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Means of control</font>&#8221; is defined as any one of the following: (i) the right to vote at a general meeting of a company, or (ii) the right to appoint directors of a company or its chief executive officer. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">A </font>&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">personal interest</font>&#8221;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>of a shareholder <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">in an action or transaction of a company includes&#160;&#160;a personal interest of any of the </font>shareholder&#8217;s<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> relatives (i.e. spouse, brother or sister, parent, grandparent, child as well as child, brother, sister or parent of such </font>shareholder<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8217;s spouse or the spouse of any of the above) or an interest of a company with respect to which the </font>shareholder<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> or the </font>shareholder<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8217;s relative (as defined above) holds 5% or more of such company&#8217;s issued shares or voting rights, in which any such person has the right to appoint a director or the chief executive officer or in which any such person serves as director or the chief executive officer, including the personal interest of a person voting pursuant to a proxy which the proxy grantor has a personal interest,</font> whether or not the person voting pursuant to such proxy has discretion with regards to the vote<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">; </font>and excludes an interest arising solely from the ownership of ordinary shares of a company<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">If you do not state whether you are a controlling shareholder or have personal interest your shares will not be voted for Proposal Nos. 2, 3 and 4.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">Reporting Requirements</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">We are subject to the information reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Exchange Act</u></font>&#8221;), applicable to foreign private issuers. We fulfill these requirements by filing reports with the Commission. Our filings with the Commission may be inspected without charge at the Commission&#8217;s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information on the operation of the Public Reference Room can be obtained by calling the Commission at 1-800-SEC-0330. Our filings are also available to the public on the Commission&#8217;s website at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.sec.gov</u></font>.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements. The circulation of this notice and proxy statement should not be taken as an admission that we are subject to the proxy rules under the Exchange Act.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">AFTER CAREFUL CONSIDERATION, OUR BOARD RECOMMENDS THAT SHAREHOLDERS VOTE &#8220;FOR&#8221; THE PROPOSALS DESCRIBED IN THIS PROXY STATEMENT.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">4</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">COMPENSATION OF EXECUTIVE OFFICERS AND DIRECTORS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">The table below reflects the compensation granted to our five most highly compensated office holders (as defined in the Companies Law) during or with respect to the year ended December 31, 2016. We refer to the five individuals for whom disclosure is provided herein as our &#8220;Covered Executives.&#8221; For purposes of the table below, &#8220;compensation&#8221; includes amounts accrued or paid in connection with salary, bonuses, equity-based compensation, retirement or termination payments, benefits and perquisites (such as car and phone) social benefits and any undertaking to provide such compensation. All amounts reported in the table are in terms of cost to the Company (in USD), as recognized in our financial statements for the year ended December 31, 2016, including compensation paid to such Covered Executives following the end of the year in respect of services provided during the year. Each of the Covered Executives was covered by our D&amp;O liability insurance policy and was granted an indemnification letter as approved by our shareholders in accordance with applicable law and our articles of association.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zde8eaee640fd4dbf93ed0f3e05e250cf" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Name and Principal Position<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Salary and benefits<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(2)</sup></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Bonus<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(3)</sup></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Equity-Based Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(4)</sup></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="14">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">USD$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Eitan Oppenhaim</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">President and Chief Executive Officer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">397,584</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">525,358</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">499,627</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,422,569</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dror David</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Financial Officer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">287,190</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">163,589</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">83,761</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">534,540</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Shay Wolfling</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Technology Officer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">260,600</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">136,053</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">103,406</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">500,059</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Gabriel Waisman<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;FONT-WEIGHT: bold">(5)</sup></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Business Officer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">270,034</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">115,694</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,750</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">408,478</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dov Farkash</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">Senior Corporate Vice President Modeling Software Division</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">249,504</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">98,309</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">57,996</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">405,809</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<table id="z8c12f55d99fe41cfb5bdb2d2ac68a27e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(1)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 96.73%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">All Covered Executives are employed on a full time (100%) basis.</div>

&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">(2)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 96.73%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Includes the Covered Executive&#8217;s gross salary and benefits and perquisites, including those mandated by applicable law. Such benefits and perquisites may include, to the extent applicable to the Covered Executives, payments, contributions and/or allocations for savings funds (e.g., Managers&#8217; Life Insurance Policy), education funds (referred to in Hebrew as &#8220;keren hishtalmut&#8221;), pension, severance, vacation, car or car allowance, medical insurances and benefits, risk insurance (e.g., life, disability, accident), telephone, convalescence pay, payments for social security, tax gross-up payments and other benefits and perquisites consistent with the Company&#8217;s policies.</div>

&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">(3)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 96.73%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Amounts reported in this column refer to the annual cash bonus for 2016, which have been provided for in the Company&#8217;s financial statements for the year ended December 31, 2016, but paid during 2017. Such amounts exclude bonuses paid during 2016 which were provided for in the Company&#8217;s financial statements for previous years.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">(4)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 96.73%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Represents the equity-based compensation expenses recorded in the Company's consolidated financial statements for the year ended December 31, 2016, based on the equity fair value on the grant date, calculated in accordance with accounting guidance for equity-based compensation. For a discussion on the assumptions used in reaching this valuation, see Note 9 to our consolidated financial statements included in our annual report on Form 20-F for the year ended December 31, 2016 as filed with the Commission on March 3, 2017.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">(5)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 96.73%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Mr. Waisman was partially employed by the Company in 2016.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">5</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">In addition, the compensation paid to our Chairman of the Board for the year ended December 31, 2016, as recognized in our financial statements for the year ended December 31, 2016, is detailed in the table below.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z77d1d0e382164979a35c9f3dcc1d3fb1" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="HEIGHT: 32px">
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Name and Principal Position</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Service Payments</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Bonus</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Equity-Based Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="VERTICAL-ALIGN: top" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center" colspan="14">USD$</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Michael Brunstein</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chairman of the Board of Directors</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">110,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">129,928</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">239,928</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z1c8eeab373674feab1b566e0c2fbc843" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 21.3pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Represents the equity-based compensation expense recorded in the Company's consolidated financial statements for the year ended December 31, 2016, based on the equity fair value on the grant date, calculated in accordance with accounting guidance for equity-based compensation. For a discussion on the assumptions used in reaching this valuation, see Note 9 to our consolidated financial statements included in our annual report on Form 20-F for the year ended December 31, 2016 as filed with the Commission on March 3, 2017.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The annual target </font>bonus<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>of the Company&#8217;s President and Chief Executive Officer for the year ended December 31, 2016 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">was divided into the following discrete components that were weighted as follows (the &#8220;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>2016 Bonus Plan</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8221;):</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">&#160;</div>

<table id="z236c0883d71a46e2bd929696cb180031" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Component</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Component Weight</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(as % of Total Target Bonus)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Company performance measures of profitability and revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">55</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Expending the Company&#8217;s organic growth engines, achieving certain strategic technology and customer related objectives and post-merger acquisition related objectives</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">A discretionary evaluation of the overall performance in the fiscal year by the compensation committee and the Board</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">Each component was measured against a target that was determined by the compensation committee and the Board. In addition, the 2016 Bonus Plan <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">payout was subject to certain threshold</font>s related to the Company&#8217;s revenue and profitability. These thresholds have been met in 2016.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The annual target </font>bonus<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>of the Company&#8217;s President and Chief Executive Officer for the year ended December 31, 2017, as set by our compensation committee and the Board <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">is divided into the following discrete components that will be weighted as follows (the &#8220;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>2017 Bonus Plan</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8221;)</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">&#160;</div>

<table id="z2a1a805498f4405fa493d790ec8f5278" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Component</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Component Weight</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(as % of Total Target Bonus)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Company performance measures of profitability and revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">55</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Expending the Company&#8217;s organic growth engines, achieving certain strategic goals according to the Company&#8217;s long term strategic planning and customers&#8217; related objectives</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">A discretionary evaluation of the overall performance in the fiscal year by the compensation committee and the Board</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">The 2017 Bonus Plan <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">payout is subject to certain threshold</font>s related to the Company&#8217;s revenue and profitability.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">6</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">PROPOSAL NO. 1</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">APPROVAL OF THE RE-ELECTION OF EACH OF MESSRS. MICHAEL </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">BRUNSTEIN, ALON DUMANIS, AVI COHEN, RAANAN COHEN AND ELI</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">&#160;FRUCHTER AS A DIRECTOR OF THE COMPANY TO HOLD OFFICE UNTIL </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">THE CLOSE OF THE NEXT ANNUAL GENERAL MEETING.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">At the Meeting, shareholders will be asked to approve the re-election of each of Messrs. Michael Brunstein, Alon Dumanis, Avi Cohen, Raanan Cohen and Eli Fruchter as a director of the Company to hold office until the close of the next annual general meeting.&#160; Messrs. Avi Cohen, Raanan Cohen and Eli Fruchter are standing for reelection as independent directors under the Companies Law. Our Board has determined that each of the director nominees qualifies as &#8220;independent director&#8221; under the rules of The NASDAQ Stock Market.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">There are currently five directors serving on the Board who are not external directors, all of which are standing for re-election under this Proposal No. 1. All of our directors attended 90% or more of the meetings of the Board and its committees on which they served since the previous annual general meeting.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Herein below are details on those directors currently serving on the Board, and standing for reelection:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Dr. Michael Brunstein</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">(73)</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>was named chairman of our board of directors in June 2006, after serving as member of our board of directors from November 2003. During the years 1990 and 1999, Dr. Brunstein served as Managing Director of Applied Materials Israel Ltd. Prior to that, Dr. Brunstein served as President of Opal Inc., and as a Director of New Business Development in Optrotech Ltd. Dr. Brunstein is a member of the board of directors of IAI (Israel Aerospace Industries Ltd.). Dr. Brunstein holds a B.Sc. in Mathematics and Physics from The Hebrew University, Jerusalem, and a M.Sc. and a Ph.D. in Physics from Tel Aviv University, Israel.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Dr. Alon Dumanis (66</font>) has served as a director of Nova since 2002. Until December 31, 2015, Dr. Dumanis acted as the Chief Executive Officer of Crecor B.V, Docor International B.V, Docor Levi Lassen I BV, Docor Levi Lassen II BV and Docor International Management Ltd., all Dutch investment companies, subsidiaries of The Van-Leer Group Foundation, and currently Dr. Dumanis is a member of the management teams of the foregoing companies. Dr. Dumanis is currently a chairman of&#160;Aposense&#160;and a member of the board of directors of Rada, both public companies traded on TASE.&#160;Dr. Dumanis is the chairman of Dumanis Investments Ltd., Dumanis Holdings Ltd., Dumanis Ventures Ltd. and the chief executive officer of ACS Cyber Solutions, all private companies. Dr. Dumanis is a former member of the board of directors of Tadiran Communications&#160;(a public company traded on TASE),&#160;of El Al Israel Airlines&#160;(a public company traded on TASE), of&#160;Protalix Biotherapeutics (a public company traded on the New York Stock Exchange),&#160;and a former member of the board of directors of Inventech Investments Co. Ltd. (a public company traded on TASE), Spectronix (a public company traded on TASE) and&#160;Ice Cure (a public company traded on TASE). Previously, Dr. Dumanis was the Head of the Material Command in the Israel Air Force at the rank of Brigadier General. Dr. Dumanis currently serves as chairman and member of several national steering committees and is the author of many papers published in a number of subject areas, including technology and management. Dr. Dumanis holds a Ph.D. in Aerospace Engineering from Purdue University, West Lafayette, Indiana, USA.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Mr. Avi Cohen (63) </font>has served as a director of Nova since 2008. Mr. Cohen serves as the Chief Executive Officer of MX1, a global media service provider founded in July 2016 as a result of a merger between&#160;RR Media&#160;Ltd., and&#160;SES Platform Services&#160;GmbH. From July 2012 and until its merger with&#160;SES Platform Services&#160;GmbH, Mr. Cohen served as the chief executive officer of RR Media Ltd. (previously known as RRsat Global Communications Network Ltd.), which was a public company traded on NASDAQ. Prior to that, until March 2012, Mr. Cohen served as President and Chief Executive Officer of Orbit Technologies, a public company traded on the TASE. Prior to joining Orbit in December 2008, Mr. Cohen served as&#160;Chief Operating Officer and Deputy to the chief executive officer of ECI Telecom Ltd. a leading supplier of best-in-class networking infrastructure equipment for carrier and service provider networks worldwide.&#160;Prior to joining ECI in September 2006, Mr. Cohen served in a variety of management positions at KLA-Tencor. From 2003 Mr. Avi Cohen was a Group Vice President, Corporate Officer and Member of the Executive Management Committee based at the corporate headquarters in the U.S. During his tenure, he successfully led the creation of KLA-Tencor&#8217;s global Metrology Group. From 1995 he was the President of KLA-Tencor Israel responsible for the Optical Metrology Division. Before joining KLA-Tencor, Mr. Cohen also spent three years as Managing Director of Octel Communications, Israel, after serving as Chief Executive Officer of Allegro Intelligent Systems, which he founded and which was acquired by Octel. Mr. Cohen holds B.Sc. and M.Sc. degrees in electrical engineering and applied physics from Case Western Reserve University, USA<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">7</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Mr. Raanan Cohen</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">(61)</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>was appointed as a director of the Company by our board of directors in February 2014. Prior to that and until December 2012, Mr. Cohen has served as the President and Chief Executive Officer of Orbotech Ltd., a public company traded on NASDAQ. Mr. Cohen has also served in a range of other executive positions at Orbotech Ltd, including Co-President for Business and Strategy, EVP and President of the Printed Circuit Board (PCB) Division, Vice President for the PCB-AOI product line and President and&#160;Chief Executive Officer&#160;of Orbotech, Inc. Prior to its merger with Orbotech in 1991, Mr. Cohen held various positions at Orbot, another manufacturer of AOI systems.&#160; Prior to joining Orbot in 1984, he worked at Telrad Networks Ltd. Mr. Cohen currently serves as the Chief Executive Officer of EyeWay Vision Ltd. and as a&#160;member of the board of directors of Utilight Ltd., both private companies. Mr. Cohen holds a B.Sc. in Computer Science from the Hebrew University in Jerusalem, Israe<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">l</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Mr. Eli Fruchter (61)&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">was appointed to serve as a director of the Company by our board of directors in August 2016. Mr. Fruchter founded EZchip Semiconductor Ltd., a supplier of highly integrated Network Processors, where he served as the chief executive officer until February 2016 when the company was acquired by Mellanox (Nasdaq: MLNX) for approximately $811 million. Prior to EZChip, Mr. Fruchter co-founded LanOptics Ltd., a supplier of networking products, where he served as co-general manger. During his tenure at LanOptics, Mr. Fruchter led LanOptics&#8217; successful initial public offering on the Nasdaq. Mr. Frutcher was also among the founders of Adacom Technologies Ltd., a manufacturer of data communications products. Mr. Fruchter holds a B.Sc. degree in Electrical Engineering from the</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Technion &#8211; Israel Institute of Technology, Haifa, Israel.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Each of the director nominees has certified to us that he complies with all requirements under the Companies Law for serving as a director (and, in the case of Messrs. Avi Cohen, Raanan Cohen and Eli Fruchter, for serving as an independent director). Such certifications will be available for inspection at the Meeting. Under the Companies Law, a public company may classify a director as independent only if (i) the audit committee has determined that he or she is qualified to serve as an external director (with the exception that such director does not have to have professional qualifications or accounting and financial expertise in order to serve as an independent director), and (ii) he or she is not serving as a director in the company for more than consecutive nine years (only a period of two or more years, in which such person did not serve as a director in the company, will be deemed to discontinue the nine year sequence), provided that a company listed on NASDAQ, such as our company, may extend such nine year period by additional three-year periods in certain circumstances. Our audit committee and board of directors acted accordingly and resolved to extend the classification of Mr. Avi Cohen as an independent director under the Companies Law. Mr. Avi Cohen and Mr. Raanan Cohen are not related.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">8</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">For information on the compensation payable to our directors, please see our annual report for the fiscal year ended December 31, 2016, filed on Form 20-F with the Commission on March 3, 2017 (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Annual Report</u></font>&#8221;).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">At the Meeting, it is proposed that the following resolution be adopted:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">RESOLVED</font>, to approve the re-election of each of Messrs. Michael Brunstein, Alon Dumanis, Avi Cohen, Raanan Cohen and Eli Fruchter, as a director of the Company to hold office until the close of the next annual general meeting.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">9</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">PROPOSAL NO. 2</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">RE-ELECTION OF MS. ZEHAVA SIMON AS AN EXTERNAL DIRECTOR OF THE COMPANY</div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt">At the Meeting, shareholders will be asked to approve the re-election of Ms. Dafna Gruber as an external director of the Company, for a three-year term commencing as of June 24, 2017. Currently and in accordance with the Companies Law, two of the Company&#8217;s directors serve as external directors: Ms. Dafna Gruber, who serves as an external director of the Company since April 29, 2015 and Ms. Zehava Simon, who was initially elected as an external director in June 2014 and now stands for re-election.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt">Herein below are details regarding Ms. Simon:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Ms. Zehava Simon </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(58) was elected as the Company&#8217;s external director in accordance with the provisions of the Companies Law in June 2014.</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Ms. Simon served as a Vice President of BMC Software from 2000 until 2013 and in her last position (as of 2011) acted as Vice President of Corporate Development. From 2002 to 2011, Ms. Simon served as Vice President and General Manager of BMC Software in Israel. In this role, she was responsible for directing operations in Israel and India as well as offshore sites. Prior to that, Ms. Simon held various positions at Intel Israel., which she joined in 1982, including leading of Finance &amp; Operations and Business Development for Intel in Israel. Ms. Simon is currently a board member of Audiocodes, a public company traded on NASDAQ and TASE, Nice Systems, a public company traded on NASDAQ and TASE, and Amiad water systems, a public company traded on London Stock Exchange. Ms. Simon is a former member of the board of directors of Insightec Ltd. (2005-2012), M-Systems Ltd., a NASDAQ listed company which was acquired in 2006 by SanDisk Corp., a public company traded on NASDAQ as well (2005-2006) and Tower Semiconductor Ltd., a public company traded on TASE and NASDAQ (1999-2004). Ms. Simon holds a B.A. in Social Sciences from the Hebrew University, Jerusalem, Israel, a law degree (LL.B.) from the Interdisciplinary Center in Herzlia and an M.A. in Business and Management from Boston University, USA.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt">Ms. Simon has certified to the Company that she complies with all requirements under the Companies Law for serving as an external director. Such certification will be available for inspection at the Meeting. Our Board has determined that Ms. Simon qualified as &#8220;independent director&#8221; under the rules of The NASDAQ Stock Market.</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">For information on the compensation payable to our external directors, please see our Annual Report.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">At the Meeting, it is proposed that the following resolution be adopted:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">&#160;&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">RESOLVED</font>, to approve the election of Ms. Zehava Simon as an external director of the Company for a three-year term, commencing as of June 24, 2017.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">10</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">PROPOSAL NO. 3</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">APPROVAL OF AMENDMENTS TO THE EMPLOYMENT TERMS OF MR. EITAN </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">OPPENHAIM, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER OF THE COMPANY</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">At the Meeting, our shareholders will be asked to approve the following amendments to Mr. Oppenhaim employment terms:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z336aa86ec2f8405e84855c4ea3ba9b8d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 28.35pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(i)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">An increase of Mr. Oppenhaim's monthly salary to NIS 120,000 from NIS 101,000;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z5cdc657f269b4e1da58254046f27cf52" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 28.35pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(ii)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">A grant of 50,000 options and 50,000 restricted shares units, in each year of 2017, 2018 and 2019 in accordance with the following scheme:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zbbbb704edd1b4d34b13dbc2731412edc" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 64.35pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">A first grant of 50,000 options and 50,000 restricted share units will be made on July 1, 2017;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z70a40af1834440e5bbe71afbd5c8fa5a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 64.35pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The second and third grants of 50,000 options and 50,000 restricted share units each will be made on the second and third anniversary of the initial grant, provided that Mr. Oppenhaim is fully employed by the Company and continues with his duties as the President and Chief Executive Officer of the Company at the respective grant date, and, provided further, that in each case, the grant of 16,667 restricted share units out of the 50,000 restricted share units is conditioned upon the Company&#8217;s exceeding the performance target of profitability in the fiscal year preceding the date of the grant by a certain threshold determined by the compensation committee and Board; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z8d0dbfc0f0f54fa896d2e0626381197f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 64.35pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">c.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The vesting schedule of the options and restricted share units is over a four (4) year period with a one fourth of such options and restricted share units vesting on each anniversary of the grant, unless they have been exercised or cancelled in accordance with the terms and conditions of the applicable incentive plan of the Company or the employment terms of Mr. Oppenhaim. The term of the options is of seven (7) years after each grant date. The exercise price will be determined in accordance with the Company's equity-based compensation policy (currently, in accordance with our equity-based compensation policy, effective February 2016, the exercise price of granted options is equal to the average closing price of the Company's Shares on NASDAQ during the 30-trading day period preceding the day of allocation).</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">All other employment terms shall remain unchanged.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The proposed amendments to the employment terms of the President and Chief Executive Officer of the Company were approved by the compensation committee and the Board, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">while considering, among others, Mr. Oppenhaim&#8217;s performance and contribution to the Company in general (in particular during 2016, which represented a 4th consecutive year of growth in revenue to a record level of $163.9 million, as a result of customer diversification, organic and inorganic growth and successful implementation of ReVera acquisition, leading to record non-GAAP net income in 2016), his experience, a compensation survey provided to the members of the compensation committee and</font> the Board, the terms of our compensation policy adopted on August 2, 2016 (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Compensation Policy</u></font>&#8221;), and the ratio between the employer cost associated with the engagement of the President and Chief Executive Officer and the average and median employer cost associated with the engagement of the other employees of the Company<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">11</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">The employment terms of Mr. Oppenhaim following the proposed amendments are consistent with our Compensation Policy.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">For more information on the compensation paid to our executive officers for fiscal year ended on December 31, 2016, please see our Annual Report and under &#8220;Compensation of Executive Officers and Directors&#8221; in this proxy statement.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">At the Meeting, it is proposed that the following resolution be adopted:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">RESOLVED</font>, to approve the amendments to the terms of employment of Mr. Oppenhaim, the President and Chief Executive Officer of the Company, as set forth in the Proxy Statement, dated May 18, 2017.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">12</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">PROPOSAL NO. 4</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">RATIFICATION AND APPROVAL OF&#160; A FRAMEWORK OF TERMS AND</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">&#160;CONDITIONS FOR THE EXTENSION, RENEWAL AND ENTERING INTO AN</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">&#160;INSURANCE POLICY FOR DIRECTORS&#8217; AND OFFICERS&#8217; LIABILITY, SUBJECT </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">TO, AND IN ACCORDANCE WITH, THE PROVISIONS OF THE COMPANIES LAW</div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Companies Law and </font>our Amended and Restated Articles of Association<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> provide that a company may obtain insurance for an office holder against liabilities incurred with respect to an act or omission in his or her capacity as an office holder.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We currently maintain directors' and officers' liability insurance that provides coverage of $40,000,000 (including $5,000,000 Side A DIC) per occurrence and in the aggregate for the period commencing from November 2, 2016 until May 1, 2018 (the "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Current Period of Insurance</u></font>"), subject to certain terms, exclusions and limitations (the "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Policy</u></font>") and subject to its approval by the Company's shareholders.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our compensation committee and Board previously authorized the Company, from time to time and for up to a period of three years in the aggregate (including the Current Period of Insurance), to extend and/or renew the Policy or enter into a new insurance policy, with the same insurers or any other insurers, in Israel or overseas, for the insurance of directors and officers liability with respect to the directors and/or officers serving in the Company and its subsidiaries, as may serve from time to time, and with the directors and/or officers serving in associated companies on behalf of the Company and/or on behalf of its subsidiaries, provided however, that the insurance transaction complies with the following conditions:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">(i) the annual premium to be paid by us will not exceed 1.5% of the aggregate coverage of the insurance policy;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">(ii) the limit of liability of the insurer will not exceed the greater of $50 million or 30% of our shareholders equity based on our most recent financial statements at the time of approval by the compensation committee; and</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">(iii) the insurance policy, as well as the limit of liability and the premium for each extension or renewal will be approved by the compensation committee (and, if required by law, by the board of directors) which will determine that the sums are reasonable considering our exposures, the scope of coverage and the market conditions and that the insurance policy reflects the current market conditions, and it will not materially affect our profitability, assets or liabilities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Further, upon circumstances to be approved by the compensation committee (and, if required by law, by the board of directors), we will be entitled to enter into a "run off" insurance policy of up to seven years, with the same insurer or any other insurance, as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">(i) the limit of liability of the insurer will not exceed the greater of $50 million or 30% of our shareholders equity based on our most recent financial statements at the time of approval by the compensation committee;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">(ii) the annual premium will not exceed 300% of the last paid annual premium; and</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">(iii) the insurance policy, as well as the limit of liability and the premium for each extension or renewal will be approved by the compensation committee (and, if required by law, by the board of directors) which shall determine that the sums are reasonable considering our exposures covered under such policy, the scope of cover and the market conditions, and that the insurance policy reflects the current market conditions and that it will not materially affect our profitability, assets or liabilities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">13</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We may also extend the insurance policy in place to include cover for liability pursuant to a future public offering of securities as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">(i) the additional premium for such extension of liability coverage will not exceed 50% of the last paid annual premium; and</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">(ii) the insurance policy as well as the additional premium will be approved by the compensation committee (and if required by law, by the board of directors) which will determine that the sums are reasonable considering the exposures pursuant to such public offering of securities, the scope of cover and the market conditions and that the insurance policy reflects the current market conditions, and it does not materially affect our profitability, assets or liabilities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The approval of the framework under this Proposal No. 4 shall be deemed an amendment to the Compensation Policy.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">At the Meeting, it is proposed that the following resolution be adopted:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">RESOLVED</font>, to approve,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> in compliance with the requirements of the Companies Law, the Policy and the </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">framework</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> of terms and conditions for the renewal, extension and replacement of the directors&#8217; and officers&#8217; liability insurance policy of the Company as set forth in the Proxy Statement, dated May 18, 2017.&#8221;</font></div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">14</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">PROPOSAL NO. 5</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">APPROVAL AND RATIFICATION OF THE RE-APPOINTMENT OF KOST FORER </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">GABBAY &amp; KASIERER, A MEMBER OF ERNEST &amp; YOUNG, AS THE </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">INDEPENDENT AUDITORS OF THE COMPANY FOR THE PERIOD ENDING AT </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">THE CLOSE OF THE NEXT ANNUAL GENERAL MEETING</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Under the Companies Law and our Amended and Restated Articles of Association, the shareholders of our Company are authorized to appoint the Company&#8217;s independent auditors. Under our Amended and Restated Articles of Association, the Board (or a committee, if it is so authorized by the Board) is authorized to determine the independent auditor&#8217;s remuneration. In addition, the approval by the Company&#8217;s audit committee of the independent auditor&#8217;s re-appointment and remuneration is required under the corporate governance rules of The NASDAQ Stock Market.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">Following the recommendation by the Company&#8217;s audit committee and the Board, it is proposed that Kost Forer Gabbay &amp; Kasierer, a member of Ernest &amp; Young, be reappointed as the independent auditors of the Company for the period ending at the close of the next annual general meeting. Such auditors served as the Company&#8217;s auditors for fiscal year 2016 and have no relationship with the Company or with any affiliate of the Company, except as described in the Annual Report. Information on fees paid to the Company&#8217;s independent public accountants may be found in the Annual Report.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">At the Meeting, it is proposed that the following resolution be adopted:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt; TEXT-INDENT: 28.35pt">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">RESOLVED</font>, to approve and ratify the re-appointment of Kost Forer Gabbay &amp; Kasierer, a member of Ernest &amp; Young, as the independent auditors of the Company for the period ending at the close of the next annual general meeting.&#8221;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">15</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">OTHER BUSINESS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">Management knows of no other business to be acted upon at the Meeting. However, if any other business properly comes before the Meeting, the persons named in the enclosed proxy will vote upon such matters in accordance with their best judgment.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zaa28da7bf3ab46b99ead49cd8fe2289c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 60%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 40%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">By the Order of the Board of Directors,</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 59.78%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 39.86%" colspan="2">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt"><img style="HEIGHT: 37px; WIDTH: 128px" src="image0.jpg"></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt">Michael Brunstein<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Chairman of the Board of Directors of the Company</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.7pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: May 18, 2017</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 0.36%">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">16</font></div>
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 1.6pt"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal"></font>&#160;</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.2.1.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal; TEXT-ALIGN: right">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal; TEXT-ALIGN: right"><u>Exhibit 99.2</u></div>

<div>
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: left; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div>
<div style="TEXT-ALIGN: left; FONT: bold 12pt/1.25 'Times New Roman', Times, serif; MARGIN-LEFT: 27pt">Nova Measuring Instruments Ltd.</div>

<div style="TEXT-ALIGN: left; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="zc8e7c6ac4fce4bfb8a70c33ddea964f6" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 96%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 34%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">IMPORTANT ANNUAL MEETING INFORMATION</div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 16%">
<div>&#160;</div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 25%">
<div>&#160;</div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 25%">
<div>&#160;</div>
</td>
</tr>
</table>
</div>
</div>

<div style="CLEAR: both">&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="zc7886f8e40b64afb926928b57738d561" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 34%">
<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Using a <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal"><u>black ink</u><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal"> </font></font>pen, mark your votes with an <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#9746; </font>as shown in this example. Please do not write outside the designated areas.</div>
</div>
</td>
<td style="FONT-SIZE: 16pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; VERTICAL-ALIGN: middle; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; WIDTH: 16%">
<div>&#9746;</div>
</td>
<td style="WIDTH: 25%">
<div>&#160;</div>
</td>
<td style="WIDTH: 25%">
<div>&#160;</div>
</td>
</tr>
</table>
</div>

<div>&#160;</div>

<div>
<div id="DSPFPageHeader">
<table id="z629a51271b384d05858fb78f3c02b4e4" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%; BACKGROUND-COLOR: #bfbfbf">
<div>
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: left; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">Annual Meeting Proxy Card</div>
</div>
</td>
</tr>
</table>
</div>
</div>

<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-WEIGHT: normal"><img src="img1.jpg"></font>&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">PLEASE FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal"><img src="img1.jpg"></font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">
<table id="zd05128ba5611415ca85b649ff27b3941" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; COLOR: #ffffff; FONT-STYLE: normal; WIDTH: 1%; BACKGROUND-COLOR: #000000">
<div style="TEXT-ALIGN: center">A</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 99%">
<div>&#160; Proposals</div>
</td>
</tr>
</table>
</div>
</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: left">
<table id="za85fb484aaf44a379cbeebe8be697ce8" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr style="HEIGHT: 9px">
<td style="WIDTH: 7.14%" colspan="2">
<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Proposal No. 1</div>
</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 7.14%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Proposal No. 3</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">For</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">Against</div>
</td>
<td style="FONT-WEIGHT: bold; TEXT-ALIGN: center; WIDTH: 7.14%">Abstain</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" colspan="6">
<div>
<div id="DSPFPageHeader"></div>

<div>Re-election of each of Messrs. Michael Brunstein, Alon Dumanis, Avi Cohen, Raanan Cohen and Eli Fruchter as a director of the Company to hold office until the close of the next annual general meeting.</div>
</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" colspan="4">
<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Approval of amendments to the employment terms of Mr. Eitan Oppenhaim, the President and Chief Executive Officer of the Company.</div>
</div>
</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">For</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">Against</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">Abstain</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%"></td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">Yes</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">No</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" colspan="2">
<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I. Dr. Michael Brunstein</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">II. Dr. Alon Dumanis</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#9744;</div>

<div>&#160;</div>

<div>&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#9744;</div>

<div>&#160;</div>

<div>&#9744;</div>

<div>&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#9744;</div>

<div>&#160;</div>

<div>&#9744;</div>

<div>&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" colspan="4">
<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Are you a controlling shareholder in the Company, or have a personal interest in the approval of this Proposal? (Please note: If you do not mark either Yes or No, your shares will not be voted for Proposal No. 3).</div>
</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: center; WIDTH: 7.14%">&#9744;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: center; WIDTH: 7.14%">&#9744;</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
</tr>

<tr style="HEIGHT: 15px">
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">III. Avi Cohen</div>
</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: middle; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: middle; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: middle; TEXT-ALIGN: center; WIDTH: 7.14%"></td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
</tr>

<tr style="HEIGHT: 38px">
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">IV. Raanan Cohen</div>

<div>&#160;</div>

<div>V. Eli Fruchter</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#160;</div>

<div>&#9744;</div>

<div>&#160;</div>

<div>&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#160;</div>

<div>&#9744;</div>

<div>&#160;</div>

<div>&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#160;</div>

<div>&#9744;</div>

<div>&#160;</div>

<div>&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%" rowspan="2">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%" rowspan="2">
<div>&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: bold; TEXT-ALIGN: left; WIDTH: 7.14%" rowspan="3" colspan="4">
<div>Proposal No. 4</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Ratification and approval of a framework of terms and conditions for the extension, renewal and entering an insurance policy for directors<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8217;</font> and officers<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8217;</font> liability, subject to, and in accordance with, the provisions of the Companies Law.</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: bold; TEXT-ALIGN: center; WIDTH: 7.14%" rowspan="2">
<div>For</div>

<div>&#160;</div>

<div style="FONT-WEIGHT: normal">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: bold; TEXT-ALIGN: center; WIDTH: 7.14%" rowspan="2">
<div>Against</div>

<div>&#160;</div>

<div style="FONT-WEIGHT: normal">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: bold; TEXT-ALIGN: center; WIDTH: 7.14%" rowspan="2">
<div>Abstain</div>

<div>&#160;</div>

<div style="FONT-WEIGHT: normal">&#9744;</div>
</td>
</tr>

<tr style="HEIGHT: 15px">
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" colspan="2"></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
</tr>

<tr style="HEIGHT: 15px">
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
<td style="WIDTH: 7.14%">&#160;</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: bold; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: bold; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: bold; TEXT-ALIGN: center; WIDTH: 7.14%">&#160;</td>
</tr>

<tr style="HEIGHT: 12px">
<td style="WIDTH: 7.14%" colspan="2">
<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Proposal No. 2</div>
</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">For</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">Against</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">Abstain</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">Yes</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">No</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
</tr>

<tr style="HEIGHT: 66px">
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" rowspan="4" colspan="4">
<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Re-election of Ms. Zehava Simon as an external director of the Company for a three-year term, commencing as of June 24, 2017.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Are you a controlling shareholder in the Company, or have a personal interest in the election of Ms. Zehava Simon (other than a personal interest unrelated to relationships with a controlling shareholder of the Company? (Please note: If you do not mark either Yes or No, your shares will not be voted for Proposal No. 2)).</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#160;</div>

<div>&#9744;</div>

<div>&#160;</div>

<div style="FONT-WEIGHT: bold; TEXT-ALIGN: center">Yes&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#160;</div>

<div>&#9744;</div>

<div>&#160;</div>

<div style="FONT-WEIGHT: bold">No</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#160;</div>

<div>&#9744;</div>
</td>
<td style="WIDTH: 7.14%" colspan="4">
<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Are you a controlling shareholder in the Company, or have a personal interest in the approval of this Proposal? (Please note: If you do not mark either Yes or No, your shares will not be voted for Proposal No. 4).</div>
</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
</tr>

<tr style="HEIGHT: 12px">
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="FONT-WEIGHT: normal; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
<td style="FONT-WEIGHT: normal; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%" colspan="2">
<div>Proposal No. 5</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">For</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">Against</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">Abstain</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 7.14%" colspan="4">
<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Approval and ratification of the re-appointment of Kost Forer Gabbay &amp; Kasierer, a member of Ernest &amp; Young, as the independent auditors of the Company for the period ending at the close of the next annual general meeting.</div>
</div>
</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%" colspan="4">
<div style="TEXT-ALIGN: justify">Shareholders entitled to notice of and to vote at the meeting shall be determined as of the close of business on May 15, 2017, the record date fixed by the Board of Directors for such purpose.&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div style="TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
<td style="WIDTH: 7.14%">
<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 7.14%">&#160;</td>
<td style="WIDTH: 7.14%">&#160;</td>
<td style="WIDTH: 7.14%">&#160;</td>
<td style="WIDTH: 7.14%">&#160;</td>
<td style="WIDTH: 7.14%">&#160;</td>
<td style="WIDTH: 7.14%">&#160;</td>
<td style="WIDTH: 7.14%">&#160;</td>
<td style="TEXT-ALIGN: justify; WIDTH: 7.14%" colspan="7">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The signer hereby revokes all previous proxies given by the signer to vote at the annual general meeting or any adjournments thereof.</div>
</td>
</tr>
</table>
</div>

<div>&#160;</div>
</div>

<div style="TEXT-ALIGN: center; FONT: 10pt/1.25 'Times New Roman', Times, serif">1 U P X</div>

<div style="TEXT-ALIGN: center; FONT: 10pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: 10pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-WEIGHT: normal"><img src="img1.jpg"></font>&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">PLEASE FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal"><img src="img1.jpg"></font></div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div style="TEXT-ALIGN: center">
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">Nova Measuring Instruments Ltd.</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Weizmann Science Park, Building 22, 2<font style="FONT-SIZE: 3.5pt; FONT-FAMILY: ArialNarrow-Bold, Arial">nd </font>Floor</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Einstein Street, Ness Ziona, Israel</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Tel: +972-73-2295600</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Fax: +972-8-9407776</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF NOVA MEASURING INSTRUMENTS LTD.</div>
</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The undersigned, a shareholder of Nova Measuring Instruments Ltd. (the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>Company</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8221;</font>), an Israeli corporation, hereby appoints Michael Brunstein and Dror David, and each of them acting individually, as the attorney and proxy of the undersigned, with full power of substitution, for and in the name of the undersigned, to vote and otherwise act on behalf of the undersigned at the annual general meeting of shareholders of the Company to be held at the offices of the Company, Building 22 (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">nd</sup><font style="FONT-SIZE: 3.5pt; FONT-FAMILY: ArialNarrow, Arial"> </font>floor) Weizmann Science Park, Einstein Street, Ness Ziona, on June 22, 2017, at 5:00 p.m. Israel time (10:00 a.m. Eastern time), or at any adjournment(s) or postponement(s) thereof, with respect to all of the ordinary shares, par value NIS 0.01, of the Company (the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>Shares</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8221;</font>) which the undersigned would be entitled to vote, with all powers the undersigned would possess if personally present, provided said proxies are authorized and directed to vote as indicated with respect to the matter set forth below this Proxy. Subject to applicable law and the rules of NASDAQ, in the absence of such instructions, the Shares represented by properly executed and received proxies will be voted <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;</font>FOR<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8221;</font> all of the proposed resolutions to be presented to the annual general meeting or any adjournment(s) or postponement(s) thereof for which the Board of Directors recommends a <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;</font>FOR<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8221;</font> vote, other than Proposal Nos. 2, 3 and 4.</div>
</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This proxy also delegates, to the extent permitted by applicable law, discretionary authority to vote with respect to any other business which may properly come before the annual general meeting or any adjournment(s) or postponement(s) thereof.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING, PLEASE COMPLETE, DATE AND SIGN THIS FORM OF PROXY AND MAIL THE ENTIRE PROXY PROMPTLY, ALONG WITH PROOF OF IDENTITY IN ACCORDANCE WITH THE COMPANY<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8217;</font>S PROXY STATEMENT, IN THE ENCLOSED ENVELOPE IN ORDER TO ASSURE REPRESENTATION OF YOUR SHARES. NO POSTAGE NEED BE AFFIXED IF THE PROXY IS MAILED IN THE UNITED STATES.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">
<table id="z4189e9b6b69a4a1f91cf34fdbccbead4" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; COLOR: #ffffff; FONT-STYLE: normal; WIDTH: 1%; BACKGROUND-COLOR: #000000">
<div style="TEXT-ALIGN: center">B</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 99%">
<div>&#160; Non-Voting Items</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Change of Address </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8212;</font> Please print new address below.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zcd7b294a78b943339380dc680714b03a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 80%">
<div>&#160;</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 2%">&#160;</td>
<td style="FONT-WEIGHT: bold; WIDTH: 13%">
<div>Meeting Attendance</div>
</td>
<td style="WIDTH: 5%">
<div>&#160;</div>
</td>
</tr>
</table>
</div>
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<table id="zfd5f2a583d504569915acefb376ceca9" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 80%">
<div>&#160;</div>

<div>&#160;</div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 2%">&#160;</td>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Mark box to the right if you plan to attend the Annual Meeting</div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 5%">
<div style="TEXT-ALIGN: center">&#9744;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">
<table id="z331dd94e26184e628e7cc8d080392bf5" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; COLOR: #ffffff; FONT-STYLE: normal; WIDTH: 1%; BACKGROUND-COLOR: #000000">
<div style="TEXT-ALIGN: center">C</div>
</td>
<td style="FONT-WEIGHT: bold; WIDTH: 99%">
<div>&#160; Authorized Signatures <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8212;</font> This section must be completed for your vote to be counted. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8212;</font> Date and Sign Below</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Please sign exactly as your name(s) appears on the Proxy. If held in joint tenancy, the shareholder named first in the Company<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8217;</font>s register must sign. Trustees, Administrators, etc., should include title and authority. Corporation should provide full name of corporation and title of authorized officer signing the Proxy. PLEASE BE SURE TO RETURN THE ENTIRE PROXY ALONG WITH PROOF OF IDENTITY AS DESCRIBED IN THE COMPANY<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8217;</font>S PROXY STATEMENT.</div>
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<table id="z346299920ea1426b82da2bfd0a0fd693" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr style="HEIGHT: 14px">
<td style="WIDTH: 30%">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Date (mm/dd/yyyy) <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8212;</font> Please print date below.</div>
</td>
<td style="WIDTH: 5%">&#160;</td>
<td style="WIDTH: 30%">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Signature 1 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8212;</font> Please keep signature within the box. </div>
</td>
<td style="WIDTH: 5%">&#160;</td>
<td style="WIDTH: 30%">Signature 2 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8212;</font> Please keep signature within the box.</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 30%">
<div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 18pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal">/</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 18pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal">/</font></div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 5%">
<div>&#160;</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 30%">
<div>&#160;</div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 5%">
<div>&#160;</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 30%">
<div>&#160;</div>

<div>&#160;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">IF VOTING BY MAIL, YOU <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal"><u>MUST</u></font> COMPLETE SECTIONS A - C ON BOTH SIDES OF THIS CARD.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>

<div style="TEXT-ALIGN: center; FONT: 10pt/1.25 'Times New Roman', Times, serif">&#160;</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 20!C0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!M%.HH ;13J* &T
M4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB
M@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M
M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.H
MH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;
M13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J
M* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &
MT4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4Z
MB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!
MM%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.
MHH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH
M;13J* &T4ZB@!M%.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM
M% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #
MJ*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;
M10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10
MZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBF
MT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4
M.HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HI
MM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM%
M#J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*
M;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10
M ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** &T4ZB@!M%.HH ;13J* &T4ZB@!M%
M.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH
M ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;1
M3J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J*
M &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T
M4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB
M@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M
M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.H
MH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;
M13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J
M* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &
MT4ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;1
M0 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 Z
MBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT
M4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .
MHIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM
M% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #
MJ*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;
M10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10
MZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBF
MT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4
M.HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ***/I0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4V/(4YIU## H 8IY.:<E,<%1D4]* !Z6D>EH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!M%.HH ;13J* &T4ZB@
M!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%
M.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH
M ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;1
M3J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J*
M &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T
M4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB
M@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &U(1G%-I5.5S0 ,,KBFI42W"F3;
MFI4H 'I*5Z6@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13
MJ* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J*
M&T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4
MZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH .U1QN/);)Z=:DK,O \,-])GY=F5_*@#.AU")KY
M@L@.T_-STKHT]:^>O"WB2:ZF\0W#2$JDL03GIS@U[[!+OL(G!ZJ* +#TM(WW
MEI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **;10
M ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZB
MFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4
M .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .H
MIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM%
M #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J
M*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;1
M0 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .JK=@3:;<CUC;^
M56*H32B*PNMQP-A'YT ?-/P_MWG@UR-03F93^3&OI'1Y#+H\.>P KR7P/H/]
MAV&L7,P^5G!Y]R:];\/QXT>+/?\ QH TR?WJBG5&?^/@4Z@!U%-HH =13:*
M'44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44
MVB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@
M!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%
M-HH =13:* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+
M>.;IK#P?=3QG#;T'YL*ZGM7)>-XOMOA9[8?>D=<#Z,* ,3QY)%I/@*Z-OQ*Y
MAS^+"N[TE1'H]O\ [@->(?$?76GU>;0@?D!AS^AKVVU8KI=N!_<6@"XP_?*:
M?0?O*?:B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -HIU% #:*=10
M VBG44 -HIU% #:*=10 VBG44 -HIU% #:*=10 VBG44 -HIU% #:*=10 VB
MG44 -HIU% #:*=10 VBG44 -HIU% #:*=10 VBG44 -HIU% #:*=10 VBG44
M -HIU% #:*=10 VBG44 -HIU% #:*=10 VBG44 -HIU% #:*=10 VBG44 -H
MIU% #:*=10 VBG44 -HIU% #:*=10 VBG44 -HIU% #:*=10 VBG44 -HIU%
M #:*=10 VBG44 -HIU% #:*=10 VBG44 -HIU% #:*=10 VBG44 -HIU% #:
M*=10 VBG44 -HIU% #:*=10 VBG44 -HIU% #:*=10 VBG44 -HIU% #:*=1
M0 VBG44 -HIU% #:*=10 VBG44 -HIU% #:*=10 VLG5;2WB\V_D12R*<$_2
MMCM7'^.+N:V\%ZA.IP0 !^= 'DOA9/,^*&E73<JS2_R-?1$=?/WP\M9;S6K.
M<#+0%B?QKZ C[?2@"1J93VI* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13
MJ* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J*
M&T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4
MZB@!M%.HH ;13J* &T4ZB@!M%.HH ;13J* &T4ZB@!M%.HH **** "BBB@ H
MHHH **** "BBD/W30 M%1*3&/FIP</C% #Z*C\P*Y!H2968X["@"2C/I3=V]
M#MIL090=U $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 9'
MK14+H^[BI%R!S0 ZBD(R>*4CI0 44[M4*!@[9H DHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X+XJW/V;P%?QK]XE<#
MU^85WM>;_%3)ALX6_P!7)NW#UQB@#GO@RWF:GJ2,OW F/Q!KV:.O*_A';+')
M>70&%FP!^&:]7Z=* %:DHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10
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M,(<9ZXH ]N*,C_+TJR,[1FN>\-^)8-7LUD:10Q'3-;D4_FR,!T'2@":BC-%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7!R ,K[U9M)3+#\WW@3F@"Q1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %1KGSY,],<5)2'@,?:@#*UZ]%KH-Q-G'&*\0\-VWVCX@Z3'
MC,2M(6'U%>I?$&?[-X0FYQDC^=</\-[87GBV:?K]F"D?B* /:%B2*,JHP*?3
M<Y+"G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]+:5<P7FGQS6YS&<\B@"W13L48H ;13L48H ;13L48H ;13L48H ;13L48H
M;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L
M48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H
M;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L
M48H ;13L48H ;13L48H ;13L48H ;13L48H ;2-Q :?BH5;<BJ>YH \Y^,-[
MY'ACRAU8C^8K+^"X\R]UF<]UCQ^M:OQ7MENK2*#&<@\5%\'+,PZ'/=$?ZXX!
M^A- 'IR#YFHIW1A[T8H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H
M;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L
M48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H ;13L48H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO(#%)%]35BH
MR!(5/I0!Y#\4-=^SZ_!:CD '=[<5T_PP!C\$Z<I7#,TA/_?1KSCQ_"][XYUQ
M.IB\GR_;.,U[-X7LTM=-BA1<*B @?7K0!LR$B:/\:?2D M[BDH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **;10 ZBFT4 .
MHIM% #L?-FHQ_K&-3=J@4[2<T >5_&+6'LK*VM$/,C"3'T-:?PNM ;!M188:
MX^;-<?\ %5CK'BFS@C.1&/*('J37J'A2P.E>'+6T(P\0"F@#IJ*;10 Z@]*;
M0>010 C?,1]*^8[RQ,7Q<20C .J!_P#QZOIW[BY/85\\>+9$L_'Z2XQF<29_
M&@#Z%R#)O'=*AMCE'_ZZ4W2I?M.F6LW]^(&I(EVAAZOF@"Q13:* '44VB@!U
M%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-H
MH =13:* '44VB@!U%-HH =13:* '44VB@!U07 RT1]&S4M(PW(: /,?B?H U
M --&N69-O%3_  GT4Z/I4BLNUF)-=GJ-LC1H95W GO5FUM4MU!C4*K#M0!?7
MI2'K2KTI&H **;10 ZF2+N6EI0><'O0!F:Y;BYT6:,C/RU\V)>2Z?XLDP"!%
M(/UKZAEC\Q)(_45\]^.-!;2->DD88^T'*_A0![_9S+<V*,IR/+!_2I;:0RVZ
MN?4URWP[U$ZEX4MKK.?,W*/P.*ZBV0QVZJ?4T 3T4VB@!U%-HH =13:* '44
MVB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@
M!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%
M-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U1I\B
ML?09IU5KB7%M<-Z(: /"-9O/M7Q"O".?M#(/RKW?38O*M5'^R*\ T6R?4_&E
MA+G.^63/X5]#182,+Z#%  ')E-25%&OSDT^@!U%-HH =13:* '44VB@!U%-H
MH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =
M13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:
M* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '
M44VB@!V*,444 &*,444 &*3%+10 9^2L[5I_LMH\F<84FKS'[HK$\5.HL=FX
M MQ0!XUH;2:]XZNVE^98I]WY5[S"86"JIY<;A7DGPYTDIK>N7!'W)M@/U%>G
MVT#0WMJN3A8B#0!K8HQ110 8I#P,TM!Y&/6@!K_-"WTKP+XJ6?V?7UG Y$&_
M]37O<O[NW<^BUX1\9[WRM3C3'W['_&@#U_P?,9?"&DR'J]NG\JV0.3]:YSP8
M=O@70?>VCS^5=(AR[4 .Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB
M@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1
MBBB@ Q1BBB@ Q1BBB@ Q0.]%,D;;M']XXH JZ@OG1*J<X-3KQ$BGJ!0D7EEB
M>:0'?\WOB@"PO2D/6E7I2'K0 8HQ110 8I,?,*6HY9/+*^]  S;)N>AKR/XT
M(?MFC2H/E)DW'\*]=DC\P UY_P#%C3!)X6-Z>MKT_$@4 ,^$$@_X06PB_B1Y
M-WXL:]&P  *\E^#5T96U&P_AM@A'XY->L!]TC+_=H =BC%%% !BC%%% !BC%
M%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !
MBC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%
M% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !B
MC%%% !BC%%% !BC%%% !BLC6Y/LNBW<AX^0UKUSGC.4+X;N.<97F@#R+X:W
MG\2V))^Y+)_6O>USFO _A%8O)X@9R#B-R1^.:^@%7!H 50%%&*;,VU>*=0 8
MHQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ11
M0 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8H
MQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110
M 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HHHH **** "BBB@
MH/ S12-]QOI0!%O#2QD="*\P^(&N-#KD%DKXW=J]+4;+9'/&VO#?%!;5OBG!
M%'\R(W.* /3O!E@L%I(Y7YYCN?W-=1&H,Q;N.!56PM1:0A0.U7HAC)H =111
M0 4'I12'I0 C_,"IZ%:\'^-D(.L1''2S_J:]V/WO^ UXK\98]^I*?2S_ ,:
M/2? PW>"-&![6\>/RKH8NKGWKG_ _'@K1_\ KW3^5=#%_'_O4 /HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "C:&(SVHI1UH 7 /6F[ HP/6ESS03F@!**** "B
MBB@ I"H;KVI:* #FN,^*Q(^'6I'_ '?_ $(5V=<7\6/^2<:G_P !_P#0A0!R
M7P4VG4=:8=2D6?RKUZ/'+=SUKQCX)2?\3+6A_L1?R->RP_<S0!+1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5POQ1G:#P7?[#AV"[/S&:[KM
M7F?Q3N<VMA9$\3E\_AS0 OPML8A;FX1>2HR:]+KSOX2MN\-M+_M$?D37HE "
M$9ZTM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%&* &T4[%&* &T4[%&* &T4[%&* &T4[%&* &T4[%&* &T4[%&* &T4[%&*
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M !1110 4444 %<?\4,?\*^U+Z+_Z$*ZN$DAL]JXGXJR'_A6FI 'YCMQ_WT*
M.9^"W_(4ULCILB_D:]?0Y05Y+\#X&6ROKA^LBJ,_3->M1_ZL4 .HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHJ%23/*.P'% #Y& AD8=E/\ *OF*
MYNFU'QG">6\^<K^1KZ+^T&WT>X>8\@-^M>#^'=-\GQ9I)N5_Y>)6/XYQ0!]"
MVX$=I" ,;4'\JL5"PQY1'W<<U-0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%-HH =13:* !SAQ39A@ BED^YNI)9
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MS0![4P&U4]J=4(/S&3M4E #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM%
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MO^]0!)BDQ2T4 )BC%+10 F*,4M% "8HQ2TM #<48I<T4 )BC%+10 F*,4M%
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M1J<?A5N+E=WK0 _%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH
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MC[JJ /RIUMG[.N>N320C_2IA["IE&% H 6BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC%
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MB$LN5\H>XZU] :9$J:3;Q <*@!_*@"<'9$M/#[F(]*4J",4!0#GUH 6BBB@
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M-[2?^A"O:KEL1R9X&PUXK\."!\6-;/JLG_H5 'MT=/:F1T]NM #<48I:.]
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MB* /1=+E%QIUI,#D&,?RJZ1R/:N<\%7)G\%:?,>25_K70JV7;VH =BC%+10
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M48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH
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M6B@!,48I:* $[5Q'BG3/[8LK6%QD"<YKN*R9HUBMP[XPC,>: %TJ)$M8=O\
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M\)?,G\<7%T?^6ENQ8^^17L/BAO\ BD]6/_3L_P#*O,_@G;"5;J]Q]W,>?RH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLWO3J'^^OO2XH 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZUZOXPU(:7H4K$X)! _*N%^'=E_:&HO?,,X<MF@#U40!;18QV%2$[%C44\L
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M&0>=J=K#[K0!ZYX<MTB\/Z?@?\LE;\2*U!USZFJ6CC9HNGK_ -,5_E5]N"M
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M$A\G/8US#^)KO4;A8@Y)/!YJUX=TZZUN_%I+"P4\;B*] L?A''9ZFDF<YY-
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M=/\ 72U\]WDI/[04JCIN_P#9: /H:)0L<8'9137_ -<GTIJ.?, ]!3\;F5J
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M44VB@!U%-HH =13:* '5!<(2H(J6F^8K.T7<#- #SP@/M2U$)!*"J]J5"=E
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MXSFL;Q7X@CT?3GD8X.*\RL?'ZRZB@W<.U 'M?D@R!QWJ3%5=.NUN=-CG!SE
M:M*=RAO7F@ Q1BEHH 3%&*6B@!,48I:* $Q4#X<ES_ ":L51NC]GM'R>N: /
M!+J[;6O'T"'G?<F,_05] )'Y=C%&/X5 KP;P?IC2^.8YFY"7;M^M?0++E,4
M+V2C%,<X>,4^@!,48I:* $Q4<_[N.23T%2U7OCFPF.<?*: /FWQ;XKN'\726
M\9)^;'!KT[P!IDL<PFD4C(SS7D%EI$FK_$J5>6 D_I7T[86L=E9H50 A0* +
M:I^]9J=BD+CRMWK3J $Q36;][MI]02'%P* *&OZ@EAIT\A8!A&Q'Y5\^^%[&
M7Q%XT6XD4F.9B[GT(KOOBSKWV&,0JW+C;@59^$NB+#HKWDB?.YRI(Z4 =Y:0
MB!L ?ZH;5J^(Q,JN:AVY?</3!J>/,<80]: %;&P@'D"LK5U,MO"Q_@(<_A6D
MJ,C%CT-9^M3K'97)_NV[,/RH MVLHD1'!^\,U;Q6%X:F-UHME-G[T8-;U "8
MHQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10
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MC;86'J] $P4*<CO1L&[=WIU% !1110 4444 5G)*29_NFOGCPB@_X3VU9?\
MH(29_,U]#W1V6['V/\J^>O WS^-H3Z7\G\S0!]& G''K2G"J6-*G>HKH_N6
MH X[QK(8=$N(5_UDV!&/7FM#PA8KIFBVEL@PIRQ^IK-\6*;SQ#HMHO*ESO\
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M_/WR/R- 'N.@M'+HEDJG*E!_*MN,Y2N+^'=V;WPI8RDY^9E_*NS@_P!5^)H
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M)(,.(0&^M=%5*VA$-LD:\!2,5=H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;12XHQ0
ME%+BC% "44N*,4 )12XHQ0 E%+BC% "4$X4GT%+BFR#]VWTH \Y^,$F?#%EM
MZ_:T8_2J?P=C/]E:I)_?ORP_*CXK3J=-AMB>53?CZ5M?"VQ%MX61\<SD2_I0
M!V[\R#VKROXQZCMTQ[9&Y="N/SKU(MA9&_NBO$?&C-KGB".T'S#S I_.@#TC
MP!:Q6?A#26VX=[=,_E7221D.I'][-4=+LOLFBZ? !_JHU'Y"M1F!5?K0 44N
M*,4 )12XHQ0 E%+BE YH KWJYMF'^R?Y5\Z^")/+\<VRG^*_D'ZFOHZY_P!4
M?]T_RKYJ\,GR_B)IZCOJ,G\S0!]+DX? J*0'=ENG>I%^:0FJ&M7R6ME(P;Y@
M.* ,6RV7WB>XN6Y6 #9[5T,)<WT^3\N!BL'PS#G37N6^_,Q_G6X'*SP_[?!_
M"@"W12XHQ0 E,E;;&34F*9,NZ(CWH \W^+UP1X9N(<_>P?U%7OA(=_@FUE/6
M0']":QOC$P%E#%G_ %JG],5N?">/R_A_I0]0_P#Z$: .YHI<48H 2FR-MC)]
M>*?BHYE!CYZ YH Y[Q!?16VF364I_>2P/C\JX+X)0FP35+>3[\LVY?I3O'6J
MR7/B0+;99(8'W8[50^%M[--XDM\@[)8F8F@#W!.E#4)TH- #:*7%&* $HI<4
M8H 2BEQ1B@!**7%&* $I1UHQ2B@!3TKEO'LI@\#ZM(IP5@.*ZD]*Y7Q^ W@?
M54/\4) H \Y^#48EU^ZD89/V96_&O;<\FO%O@PI%U>3 <" +^5>T1\Q@^M "
MTUC\ZCU-/Q36'S*?2@!''S!17/\ BG5$M=*N8D;$@6MLW"H9)'. !7AVM^)9
MM3\:3Z<A+1L0* #PMH$GB/5&N;I=ZHV>:]CLM/6Q'EPKM  S5+PGHT>D:86
M +C)K?MR'3S#WH ;ALC-/D&)(_H:EP#32,\GM0!%!\\*@]\U\V>,YOL/Q>OV
M0XV2Q@?B!7TC&?+MB3_#DU\S^+D.H_$^Y=>?.E0C\,4 ?2=E]XR'NB_RJROW
MF8=ZJVQ/]FH_<H!^E68.8%)H ?12XHQ0 E%+BC% "44N*,4 )33PQ;T6GXJ.
M7[K#_9H I:HY_L:[E':!OY5X;H-LUQXPM&(R3()#^=>W:M(L7AR<.<;XBOZ5
MYCX2M%?QE HYV09_6@#V <.1[4_L/I3&XE/^[3QRH^E "44N*,4 )12XHQ0
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ML$.1)\Q'TH D^#^F[[F[N77A6&TU[0>4XKA_AKIWV+P_'+C#3#)KM(F)&#0
M0C -2#Y5)IA^4TLOW* !5#*V>]<-?SIJ7BN.WCY6U7YA[@UU=_>K96K.S8PN
M:\^^'\IU36-;OFY_TDQJ?8T >C0R!GC'JF:LU D BG3_ &4Q5C% "44N*,4
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M[7R_ U@I]&_G0!U%%%% !4-T,VDV.NPT*Y^8]NU9^N7RV&@W<\AP1&P7ZXH
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M6DW>V[- 'T% N+1(O:I8>(POI3<%980.F.:>G^L<>E #Z*** "BBB@ HHHH
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M.U !1110 4C<1&EI@.=X/84 8_BF_%CHTK9QE"*\1^'.GFX\0:1,XR'>8O\
MKBO3?B5<&+P!=39_>@@+_P!]"N5^$%NL^KZBV,I:*AB^K YH ]8L;9X8848_
M<)S5ZJ=O([^2?[Q.:N4 %%%1L3AR/PH 68[89#Z*:^?=<G_M#QK%D[A&Q0_C
M7M>M7IMO#\TN<.5.*^?]!AN[WQ6K2*23)DT ?0^E6PT[1[:+&-JXK0(VU7VN
MUA$#][BK2@E>: &/S@U)]Y!475L5%-<#F-#\R]: .*^).H&QTJ7:V"4.*K_"
MK39+7PP+E\[KMA-S7,^.;V76_$-KID)W?OE60>V>:]>TFPBT_3X+2(82) HH
M NGYU4BG4NW"X]*2@ HHHH **** "BBB@ HHHH ***CB)9VSTH DHJ+S!N85
M(G- "T4&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BF
MT4 .HIM% #J*;10 ZBFT4 .HIM% #8SD2?6J]S/]GL)9O[@)JPG"25G:WD>'
M+TCKY+8_*@#P:XOO[7\8PQCG.H+)^M?0(3S')'9=E?/G@C3I9OB' L@R/+,W
MY&OHF/"\_P!YLB@#S7XLR_9]"L[%6YGN%0_CFMWX=Z#_ &/X>$7]Z3S/TKA/
MB/>G5O$VGVL1RL%X@8?0UZ_IH$%I G0% * -"BFT4 .HIM% #J*;10 ZFN,J
M112CK0!7EPJLWJI%?->GVS)\4[2 G"_;&;\Z^C[K<81CU-?/_B;;H_CU[G[I
MCPX/UH ZSXA>)2-3O=#5L$0H0?K4WPH\.2:3?ZA<RDL9HU()K@_&S27WBV>]
MB.0UM$<U[WX:MDCT6WE ^9XES^5 &W%TJ1NE,C'%.8T )0.M-I5^]0 IJ-AD
M$>U2&F&@#Q7XEMYGB+14_N^8*].\'Q^1X9L8O8_SKRWXCG;XHLR?^6;$?GBO
M6= 7;I%HH[+0!L4C'"DTE'48H @=MENK>IKB?BQ?&W\-QVZ'#32HN![FNUN5
M)ME _O"O.?B$K:GXKT?3$Y!.]A]#0!TNAV7]G^"Y8>F(#_*O)_!ZF#XB6<@Z
MO&V?SKV[4(Q%IK0)QNB(_2O(/"$:GXFI;MUAC84 >X[0"7]!35 =TE!XQBJT
M<ID%S$#\PR!3K#>D"QR?>H N44VB@!U%-HH =13:* '44VB@!U'<4VE'6@!C
M?/$_L:\E^,MSMBL(?]L5ZU#\T;_[QKQ3XRL7U.V0?P8- '>_#FW%OX4@&.KE
MJZX2#CW.*YWP8NSPQ:*.I4']*VT5F12.S&@"?;L<MZUQ?CC5O[.M"0W,H*UV
M9F1D;_9%>.^,[TZOK,%E"<^5)EA0!3^&VBO<:NEU(I^21F&?>O;8(_*!0=JQ
M-"TF'2[%9%0*2@)K?[;O44 .HIM% #JJ:DAEL70'DD?SJS4<HW,J]B#0!YS\
M6KQK30HX4) GQT]B*Q_A/IPNM:U34"OR?)M/X4WXIZE%-IIMF.9;0X;_ ($>
M*ZOX5V/V+P%:S,,32@ESZ\G% '=X!<'TIH&)']Z;;D^7N-2-Z^M !13:* '4
M4VB@!U%-HH =4+#-ROIBI*1^(V?N!0!X9\<+O=K=O9(>!;^;@>H->B?#BU%M
MX+T]\8,T:R'\J\G^(>[4O&L+GE=GV?\ $FO</#5J;/P[I]L1@Q0JI% &XO2D
M;K2CA:83S0 M%-HH =13:* '44VB@!U%-HH =4$O/F#VJ6HR,L_TH 5A_J17
MA?Q7F\W6]1C!_P!4D9_45[HQ^=?85\[?$&Y\[Q1KO/'EQ ?G0!] :1QH%E_U
MP3^57JS]*/\ Q(K$?],$_E5\T +13:* '5EZ_=_8]+>0=>*TJP_%"F;2I5'\
M*\T >3^+IOMGA/Q3J"#!E>###V.*ZKX.OG0YXF.64+G-8>IZ:\7PDN(Y1^]F
M=2??#U<^$ESON=7B0_*GE@?E0!ZTG"K0PR,^M-B^XN:;OR2!_#UH :D6Q_,8
M\55-_#-=M;AUR#ZUE^)/$D&GV$@W ./>O)M$\5S_ /"5"664^5(<CF@#W3;Y
M,RL3P:L1C$C'L:HQ72W^GI-$<YQ5P92V!/WJ 'S#*$BN$^)>M#3/#3(&^=UQ
M7=1G,>6KP;XLWLM_XEM--B8E3( 1^- &_P#"71O,TZ34Y4^9CD$BO6XCF)?I
M6+X:T^+1_#EK %VDH ?K6RHPH'I0 ^JC1^:S@^N*LTR7"!".["@#YDO/^1RO
M6'_+'5#^AKZ6TJ3S-)M7_O1 U\XWL7E^(M>E;^'4)&%?0?AV3S/#FG/_ 'K=
M3^E &O3:44T]: %HIM% #JC7YE/L:=38>K"@".89^;^Z#7S[%,VH^-]-;)/_
M !,70_A7O\\@2RGD/\(->$^"K4WGBPOC(MKUY3[ F@#W:Q_U;*?X3BK=0P (
M<]FZ5)0 ZBFT4 .J$OMDE]@*DJM.<><?I0!Y[\7[@0>'8;//^OSQ],&H/@G:
M$:!<:@>MQQ^1(K/^-DS?;M!A!X?S,C\!75?"F 6GP_LD(PS,_P#Z$: .QMUV
M6Z'^Z35FHUP2Z#MBG4 .II(!"GO15>]E\M _H0* .-\?ZB+2TBM@?O DUQO@
M4)=^*-P48%2?$?4=^OF#=]P8Q]15[X8Z-/'+]L<'![T >KK(#-Y?85*S "JT
M4;"X9STIYRST */6L/5;E=*@GO7; 8'&:Z# "<UY%\4M?\Y4TBT?$Y8 @4 0
M>"+$ZKXRNM5D&4+$KFO88JY'P3I/V'PY;$KB<@;S781B@"0]*;2L:90 ZBFT
M4 .HIM% #J*;10 ZBFT4 #_<-"X2+-+U.*ANV(55'K0 P1DOOJS'TJ,NJHJG
MJ14D?2@!QI*&IM #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10
MZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBF
MT4 .HIM% #J*;10 ZBFT4 +BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M%
M##PKBL;Q1<"V\,71)QF(C]*VNI85Q'Q.NC;^&Y(P<;QB@#B/ !6;QK%.O.VP
M8?K7LGF!;>&1C@8!->,?"&%FO)KE^=JF+->I^(KP67ABZES@Q(>?PH \]\-Z
M5'K_ (LU:X8[E@OVVGZ&O7!;JJHO]VO*O@I*;O3]5O6Y\R^;G\!7JGF?Z?Y?
M^QF@";%&*6B@!,48I:* $Q1BEHH 3%(>!FG4UQE"* &F,/'C\:^>_BC!_P 5
M^T!XCDC4$U] B8"5H_10:\5^+U@_]K/?H#E8QR* ,7PW =>\13P.,Q"-4#?2
MO?+-4MK2WMXSD*,&O*/A3HSOHL=\R_/*[#)KU2QM)(&)D)/I0!I)2'K3EZ4P
M_>H 7%*!S10.M  :C;I4C5&W- 'A'Q-N!_PE+*#RDB#\\5[3HT>S3X0>R#^5
M?/GQ$NM_CV^CS]V:+^E?1UFH6UCQW1?Y4 38HZ4M,E.$S[T (0"I!_AYK@F@
M^W?$2"[ RL$;#-=K<2^7%<'/1"?TKB_ MTNH3:E.1EDE"@T =C(OVB.-C]#7
MA$]^^@?%R>4<*\X0?0U[LS^6C#T<"O#_ (L:>UGXLM+I 1O<2DCV- 'N"!89
M!,#_ *S!-63S=J1]TK7#>$/%2>)H/L\?WH1@UWD*XB4'[P&* 'XHQ2T4 )BC
M%+10 F*,4M% "8HQ2T4 )BCH:6FMU'UH ;!P&'^T:\7^*J>9KCY_AC!KV=?E
M)^M>-_%9A'K,A]8EH ]+\*1[-&LU_P"F"G]*VDP@QZFLKPY_R"[+_KU3^577
M;]V)<\(Q)H Y/QMK_P#PCT)*MAGKC/ UB^MZS?:A,IP%!4FLOXCZL?$>NQ6-
MLW*M@XKU+P5HHTG1HT9<22*,F@#?)W0O"/X4%70/D4>U0)"4DD<]"!4RMN/T
MH 7%&*6B@!,5#=.(86D_NBIZP/%NIKIVD.S'&Y30!X5XLFDU?XB7&GIEH[UU
M_P#'0*]_T.Q6QTQ+!1A8E&*\3^'UG_;_ (O@U1AN6P9O,/KN!Q7OEL0VZ0=&
MH D*[8MHH'*BD24.Y7TI%/[QQZ4 .Q1BEHH 3%&*6B@!,48I:* $Q4%U*(H'
MR<#%6*P/%]R;+0I[C.-JG^5 'C&I_P"F>($9/F8:J@_#->_P)Y:!?05\\^!+
MD:SXO="-P#&X_(U]$Q.)(T<=QF@"7^&FCFG'I3%Z&@!<48I:* $Q1BEHH 3%
M&*6B@!,48I:* $Q36& Q]:?3)#\E $9^_(?1,U\UZV#J'B>\'7[1($^N#7TD
MYP)S_P!,S_*OGG1[8W7B72&(SYM_,I_ F@#Z!TU-EA:Q?W8E'Z5='-00C;+L
M_NJ!4T?*_C0 N*,4M% "8KD_&M^-/T6\<'YV9 H_$5UM>;?$)7O]?TG2(CS=
M,20/]G!H VO$6FQR>#F@7'R(&Q]>:XOX*1;KW72>SH/YUWVLDVMG/')RKQ<#
MZ"O/O@9=K/>^(&'3S%_K0![&!M"BH,B.&>5CCBI@VXK^-<]XRU=-'T&5V."5
M- 'C'BK6;C4==FLX\LF['%5=1TDZ8FERX(9HR36SX#T@Z_J,U^R[EW9YK4^)
MD26,FG*%P!$U '<>!;HS>&XV8]"!75N^Y@G:O._AS>BY\) K_"ZBN^?,95C0
M!#K-X-/TYI,XQ7DUMI)\0^+8]0=<JL@8'\:Z_P"(^H^5H$A5L';4GPYLP_AF
MSNW7YI8]V30!V+1!DC0=%Q4^.:C@!&[/K4E "8J*?YE3V<5-4/1&8]FS0!X#
MXXM1IE[K##@RL\M>Q^#9"_@S17/5K2,_I7E/Q=(_M\P+_P M;,M^IKU7P>GE
M^#M&3TM$'Z4 =$O2@CFB/I1WH 3%&*6B@!,4U.)F'M3ZC'_'RW^[0!CZY<?9
MO#5_+G&U37DGPQ9FUK6Y,9!CW#\Z](\<2^3X"U:3.,(U<;\(]/,EM<W)'^NC
M S0!ZPA/E6I]0,U8Q46 J1C^X*F'2@!,48I:* $Q4%PF8I".^*L5#G=&!ZF@
M#Q7XS2%O$6AKV0OG\0*]#\(Q_9_#FFQ+T^8G\Z\Z^+@\S78'_P">1X_'%>E^
M$<2^'[0_W!0!T$9(NW'KBIL4PKB=3ZU)0 F.*HW:F6U?/]X&K_:J=[*L%E+G
MM&S?D* /GOX@W1;QG=;#E?,4#]*]N\&1)#X<@8 9*\UX1Y9U[4Q<CDRR?R-?
M0&A6+VNC1PGK@4 :P;,(/K3U0 YJ$?+$J'J*>TH4'- &5KVKIIUL[;P"%)KP
MC0Q/XI^)#7$JDQ!B03TKHOB7K[I>"UC<DR';Q[UT?P[\,?8=.2[D3]XPSG%
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M_A,(%PTC>8?KBNU@CRWG-][;BFVENME9)$    *L,VU%QW.* %HHHH ****
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M//L*\4DL)/%OC>2YP3$)./3B@#TOP)HL6D^&+=D7$DBY-87Q:M(_^$46]?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6A#1O#_VAEQ+<\MGV- '<+\\Z^BBG@GSI/PI OE1E^YIT8R-W]Z@!U%+BC%
M"44N*,4 )12XHQ0 E*/OBC% '[P?2@!N,RUXW\9)&NM<L--3GS$#8_&O8V?:
M)&]!7D&MQ'7?B?8L!N2&+:?SH [WPCI_]F^%;:'&#L&?RKHTXB3Z5"(Q%%%
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MOS#BO9-'3R]'MX_2,?RH N'I'CM3J(QE*7% "44N*,4 )39>5QZT_%(WWD%
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M,>U %[RQ;QJB<*.*EIJ-YT0SUI^* $HI<48H 2BEQ1B@!**7%&* $HI<48H
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M%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4
M)12XHQ0 E%+BC% "44N** %HHHH **** "BBB@ HHHH *#P,^E%(WW3]* ,[
M59@='NI1P8T)_(5X#X8TJ75/'!N,Y#R^=^1KV_Q/<)9>&M0<G"M;OCZXKR+X
M4W7G>*K9C_J_LC;C[YH ]1\37:BU>QS\[0EQ5;P-I,EAH#>9UGE\P?E67XOF
M<WEKY?,SW*QX_P"F9/-=[:Q"*SBC3[JD 4 6H1MC*TQ(V5R:FZ&C- !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %5M0?9IMRWI&W\JLU5U, Z7
M= _\\V_E0!\]?#__ )'?PZ_JUQ_6OH\8 XKYI^'#F3QMH*_W3<?UKZ.MG9K+
M<WWL&@"SVJAJ:YL9L'H,T^UE<VB&3[QS61KUZ\-I'&I^:0X(H J>$[9OL]S=
M?\_+AORKJH5(W'UJI8VRVFFPQIT45=S@J/:@!]'3FFY-&<T 'F#.*3'.:3:,
MYIWM0 4444 %%%% !1110 4444 %%%17#%+>1AU H D->.S68F^+\4G!\O#?
MK7K0=BB'U7)KY\MM<ND^*4[RD@>:4'T!H Z?XFNVH:_+I\;9_= X%=SX!TP:
M+X:@@*X9CDUY'IEQ?Z[\0(IY5+1/<F)C_L@U[[!"(V$0^Z@XH LE0IW4[.0#
M1U&*!@#% !14;%@U2@?+DT )67KET+"S^UL<+&"35YG*RG/W17E?Q8\1RH^G
MV%FV5G9ED _"@#/TZ=O&OB,N,M#&W3M7KT=HL,4,,8PJ#H*X[X=^'H]+L1<!
M<-(,FNYC8EV]J !SNS'Z4Y?[OI1M^8MW-*!R3ZT +1110 4444 %%%% !0/6
MBF,Q4D]@,T 4K^79:7+9QA37G?P[B_M36]2O7&?)G* UM_$#6AIGAJ1XVQ+)
MT^E+\+K%;?PR+L#YKLB5OK0!VH^:?Z#%)&<E_9J>!@D^M 4+G'<YH 6BBB@
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M05XMX;M?[9\<S7-P,S0W3#_@(/%>X ;1@=AB@!B/MB8^AJ0<@&F[!M*^M.'
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MXH \*^%=N7\<V#?\\FE_7-?1B )A*\,^$UL/^$GFEQ_JVX_'->X.3N8CL10
MR;"R(@XKFM8/VC6X81RJFNDNSL?>>R$_I7.Z#C5)C>=0"<&@#IU&(8UJ5O\
M6+]*8?OJ/2I&^\* "BFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZHYQNB
M9?48IU(PSM^M "*F(A[+BO!M3T(CQP\RC'[TM^M>\,^R!R:\ZUI(H?$4+,/]
M:<"@!G@#1D\DW3(-RW3G->D1?,S/^%8/A:S-MI4B@8)F9JW+8$1$'KNH GIK
M'#+11C)'M0 LF  :';$1(ID^2O%"D"/#=Z ,;Q+JZ:5HTD[$ XKQ'2WD\6^(
M?,8%EA?(S[UT/Q;UMW9=/MGY8XP*V/A9X8-G8O<SI\T@!!Q0!Z3IULMK8QQ
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M_LS4=19?F:;<I]L5ZM;OYL0D'1N: )<48I:* $Q1BEHH 3%&*6B@!,48I:*
M$Q1BEHH 3%07$Z6VUW. >*L5Q'Q$U7[#9P(C88L>GTH X'Q_XEEU*XM;>$E@
M)V7BNW^&FE^7HC7$R_O'8CFO/?!FA3:P;>]F!91=OUKW#2[9+2T$<8VJ">*
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M]Y^==8#D9]: #%&*6B@!,48I:* $Q1BEHH 3%1N^W:%Y!J7M4$2^7& _)S0
MK_NH6*\GBFMG]XWKBI%0Y?=T-'!B^M %"[C/D:@Y_P">1Q^5?/W@EL:O9_\
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MH :\CI/S]W->?>/KC[/H^HW9.)G1H$]U(KT&_<)%QUKQ_P"+&I :GI>EJ?\
MCXVY'U.* .D^#]@;;P6Q88:5MQ_(5Z)&,1J/05C>%[(:;X?M80,94?RK;H *
M*** "BBB@ KS7XPW[6.BV<T9^=9N*]*KR7XSH9;32;<?\M;K% 'H'A^(2Z59
MW+??EMD+?E6T!@8]*SM#3RM*LXO[D"C]*T: "BBB@ HHHH **** "D(W=>U+
M10 9[4W;@8IU% %2]'DZ5<A?X8F/Z5\U^%93>^*=),OW6>3/YU]*ZE_R"[O_
M *XM_*OF;PT/(^Q7G0Q3%?S:@#Z3M96WSQ_PIM J_MJG:I\SG^^%/Z5=H **
M** "BBB@ HHHH *:2-P%./2FA#UH <WW33&W"+(ZTI/S 4C2 2!/6@"))<(=
MWWNU)=7D5G!YL[!5 Y)I+J+:?-S@)R:\W\=>)?/7^SXGP7XR#0!SGBGQQ=WN
MKW%A8N7A(*G![9K(\$Z->7'B,>=&?*9N2?K5'P[I<MIXG2.4&3[2^W)YZFO?
M=(T&'3U#!%#>N* +D=BMG:1V\0^5FYJZ85957LO2G(P=>>QIU $<P/E$CJ.E
M?/GQ2PWCVZ5NKVB#]:^A7X0YKYX^*?S?$>0CHMLA/YT >Y:)E-!TU>PMT_E6
MC*6#QXZ$\U2T4A] T_\ ZXK_ "K3X_(4 1+*&E* ]*EK'TN8S:A<9_AK8H *
M*** "JC0K]G*]A5NH&_U+4 ?.GC&0Z/XSUTP_P!^#]<5]#P.1%9+V:,$_E7S
MI\1Q_P 5CKO^_;_TKZ+MES!9'TB'\J )TYD<^E24Q!RY]:?0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 -HI<48H 2BEQ1B@!**7%&* $HI<48H >.E9'B0D>'-2(ZB
MV?\ E6N.E9'B7_D6]3_Z]G_E0!\VV3!K6'/_ "UMVC_X$>E?07@6U_LSP9IU
MO(,.L8#?6OFWP[+-=ZIIMGM) G5C],U]3QHJ>3 OW=H:@"]12XHQ0 E%+BC%
M "44N*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4 )12XH
MQ0 E9^N6_P!JT6ZA(SE*T<5'<#_19AZH?Y4 ?/7P_/D_$?3(1P%\W/Y&MOXM
MWHN-;TB&,\X=?SKG?#4GV+XF^8_RB+?^H-)JMT^N>.;) "PBDH ]E\!:6VF>
M#K:UD7#J"2/QS73P'<';L:KQ$Q%8@,*4_I4]H,6ZYZF@"6BEQ1B@!**7%&*
M$HI<48H 2BEQ1B@!**7%&* $HI<48H 2E')HQ1T- ".Q$@ JGJN5BCD[(V35
MS&9_H*S[ZXCGF>SW#)3I0!SKD?VA!;1_Q2>:X]C74QRI  &Z]JXG0)VOM6O[
MD\B!3"/P-6M;U:6#5X;< X,:F@#L'DWXV]*>4YC/H:K:9F6U5SU(JZ3SCTH
MKLQ-V!V%8/B_5H;'3)MS ?+S6[<LMO%).3C KPSQKXA?4]1^P(Q*R-M.* ,7
MPAIK^(_%RM.-ZK(3+_N]J^B=/5;6T$ XV=*\Y^&^A?V:AOF7#7/R'/;%>DI'
MND9O6@"6$G<2:=C]XQ]:5EV1FA.4!H **7%&* $HI<48H 2BEQ1B@!**7%&*
M $I'.$^IIV*:ZY7'O0!F:M=I9Z?-(3@ XKR_14&L^-//'S+"<5T7Q(U,V6CR
MQ@X9I 0*R/@[ UR=2O)!_P MN"?I0!ZL1M*(.@%2DU']ZX^@IPY+?6@ HI<4
M8H 2BEQ1B@!**7%&* $HR/QI<4S&9L=@* (?,,;Y8\5P7Q#\4?99;73K23%P
MS!B >QKI/%FJ)INFM*&&X"O"-0OI]=U^#5$!=E<1D#T% &[-H;ZAXAM)[=<R
M?*937M.BV<-GIJ1Q#&.6^M<YHVF&P^SW>S+3* >.E=A:Q!8" >IS0!)NW<5G
M:\_V;0[N7IA*T$7#UB>.9?)\':A)Z1T >(> H_M'Q!C?KMF+5](8KY]^%$/G
M>+YI/[H#5]!]J (C3&E5,$]J>_6LO59?)M6;.,B@"A?%-1U2)5Y"FNACC$:A
M!T KF?#B-+<M,PZ&NJ')S0 IZ5R7CG4DTOPU?RL<%E %=8_ KR?XX7#1>%DC
M0G,IQ^HH PO@CI)>VN=1V\NV0?Q->WVY;R%W=:X3X06'V'P5;AEPS Y_,UZ
M%P,4 )1C,BGTI<4H&!F@"%X!()@1]X5XS8>%)[;XD7%W,A^S[\IQ7MP(QFJ4
M]I%/,& &X=: 'D;FC(^Z!4V<\BF1 *&3TIR#Y!0 M%+BC% "4T.KJQ_N=:?C
MFJ^SRXYC_?- $# S$LWW!S7A'B,OXA^+5E'%\T=K(JGVPU>S>(]371?#<]P6
MPP0D?E7EGPFL&UG7[W69E^]*Q!/YT >UQ@+&D:]$%3YXJ"URYF)[,15@#@4
M)12XHQ0 E%+BC% "5YK\3$6XUSPU;=<WHR/PKTO%>7>*Y#>?$G1K?J()E>@#
MTB(>2 @_AC JP#P#4,@^>0_[-3*/D7Z4 %%+BC% "44N*,4 )12XHQ0 E%+B
MC% "44N*,4 07B[[*=?6-A^E?,[(;"VN+8\-'=)Q]6KZ>*[E*^HQ7SCXQM_L
MOC&^M1]TW$9_E0!]!0MMEME_O1@_I5RL^V(E>UD!R!&!^E:.* $HI<48H 2B
MEQ1B@!**7%&* "G%@!3<4A&3B@"/)+,?2A5RV\T\JJ*<G&:P?$6O0Z59,1(-
MP'K0!3\4^*+:SL[FW#@3-&57GO7A]YJ,FHZS;0 DSD@4_P 0:C>:O>2W,2LV
MS+#%=MX*\!K=FSUNX&V3Y6P?SH Z3PEX85#%<WB?O4(*DCO7=E_WH2JELY,K
MQ[<+'TJYY>7$GM0 C@HZXZ$T^EX<9]#1B@"*X)^S28ZXKY]^)K*OCB^+?>^P
MICZYKZ&=-R%?6OG[XOV;1>)X[L XF41$_2@#V/PS<B?PW8LI^[ H/Y5M"4!P
MI/+"N$^%=^+_ ,->6Q^:,E<>PJIXT\8'1/$MI:(W4@&@#N+2(6U]+GCS.E:5
M9UH_VR*UN?[PR:TL4 )12XHQ0 "HO^6)J7%1_P#+(T ?.GQ#3/C37!_MP?TK
MZ(LL-8VK>D:_RKY]^((_XK37?]Z#^E>^:+)YFD6Y_P"F8_E0!<7[F?6BA/N"
MEQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44
MN*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E
M%+BB@!:*** "BBB@ HHHH **** '#I6?JT!NM+N[<=98F0?B*O9I",T >,>#
MO 4EGXD^T2I\D,;+T_BKUFUB;S8V;^!-IJU#;I"TC*!ESDT]5"DX[F@!U%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)5WQ,OJ,4
M^FN<+D4 ?-/C(G0O&=[( 5P1@_45J?#&Q.J>)I[R1=RQ8//TKM?B/X/BU&;[
M6$R\I&[CTQ6UX#\,PZ18/*JX>4<T =7%(DT,<X''2I^%95%,BMUA@$(Z"I=N
M6!]* %HHHH **** "BBB@ HHHH **** "BBB@ IK=5^M.IDIQ$S>@S0 C.$=
MB?2O)F\4[/'MTA?Y(H\D9]Z[_P 27QL= O+K."D!8?6OF>WU>2Z\1QW ;+W4
MOEM],T ?0G@[3FMK"XED'-Q<-,/]TU<U+1C>ZFEPJ\!0*T=#3&F6Z-P1$!6E
M'A3M- #+9/LULJ'M3N<,WM3F!9\=JCN)4MX6+G Q0!S?C;4Q9>'9G#8.TUX7
MX6MY=>\0[SEL/FNC\>^(9[Z^.G1$M&6QQ79_#OPG!8VRW6W#D9H [&"Q6UM8
MXD7'RC'UK33Y$+>U.*!BO^S05RNWL: $WB6(XIRC" 4B($7:*=0 4444 %%%
M% !1110 444A.#0 M12R;&Y[*31(Q%PBCH122[,2,YX53F@#QWXI7!NM4L;9
M#Q)"SD?2NR^&]@-.\-(^W!FPU>7^)+TWWB5R#GRKE8(O=">:]VTFS6UTR"W
MP(U % %Y!SN]:<1@T#@8HH **** "BBF$D2>V* 'T4W<&^[ZT[(W;>^,T %5
MKZY2SM7F8@8%.\\ OD\+UKRSXD^,/)A$%I)G)VG!H Q?&/B;^UI7M(7]N#5G
MX6^&3]IF:[3<GWAD5R'A'3;G5+R*YF0G?<;3]*^AM*TJ+3(5\L $KS0!:,<4
M4 !484\4MH2D95NYR*>Z;UVFG*@P/;B@"3'>N6^)#[/ &J-Z1_UKJ:X_XG/C
MP#J2^L?/YT >>?!J/=X@O6](4->Z(<K7@WP;D8:WJH'\-M&17N7F%8L?Q8H
M>_6N5\87PMK:%,\L<5LR7FRRD+']XIZ5Q6H2-K?B7R1\T" 8/O0!VNCQ+!I:
M/CDBM1!A:K6T6RU2(] ,5*'(G(/W10 ^2O'OB_<K>7VFZ6.6W'(_*O79)502
M.YPBC.:\=B2/Q3\5[O<=UO 5\L_\!YH ]-T.P_L_2+6V48PO2MJD5  H'\(P
M* <C- "TV0XBS3J1AN&* &@DP*:K1)(E[(['Y2>*M@87;Z4$9H @Y-V3V'6K
M Z4T+@D^M. P* "BBH9682*!T- $U1R,-RIZ\T]R!@>M0RE4<R,<!10!Y'\9
M=;,5I_9\;89QC KJ?A9I(TOP9;RLN'E0.3^%<#XFBB\1^/XK8G<@;'ZU[=I]
MFEEID%F@PD<844 21$1IN_OM4W>F&,%57^Z>*?0 4444 %%%% !7FS6QN?C%
M(I&1#;*X_.O2:QXM*B37I=5 _?/'Y9^@H UI%PC'VI5^Z/I2_?3![T=!B@ H
MHHH **** "BBB@ HHHH **** "O _B%!M\;S28^\P/Y 5[Y7C'Q,LVCN[K4"
M/E5U /UQ0!Z/X:N1/X<MK@G)(Q705YA\-=6>[-Y8N?W%N5"?C7I>XEQCI0!)
M12.RHN2:CRV* ):*9'DGFF!SYY4]* )J*:QPPQTJ)9<2'=]WM0!/3?,'FXJ%
MY&WG'3'%8NJ>(;+3XI$EE"W&PE1GO0 WQ/KL>FJN6'YUX?XR\33:G?B"&0X)
MQQ3=6\2W^J:G<PSYVG(B]SVK>\%>"6U*1)[V,A@<\B@#H_A_X9CDTSS[J,-D
M<Y%>C"U2VMH([==J C@4EC8Q:;:K;1X"]*O;1A1_=H ADV1':!\SC%3)]S9W
M IKQ!W#GJ*>!@YH 8@*=>YJ2@\_A10 V1]B%CVKS#XJZ1]JT'[<%YMSYA/M7
MILZ[H'7U%<[XSM3<>&)X,9$D>TT >;?"O4CIMQ=6TA^581+CZUB^)K2X\3>/
MH6A8E0PJ#1+Z+3];82MM\Q/*/T%3^"I+R[\?,ZH6@63K[4 >[Z/ UKIT$$GW
ME4"M*H"<21^IZU/0 4444 %1K_J33VZ4R7Y% '>@#YZ^(?\ R..O'W@_I7N'
MAF3=HD/L@KP_XCY_X3C5D'\9BS^0KV7PHY.AZ?\ [:G/X4 =!&?D7\:DIB#!
M(]*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%-HH =13:* '44VB@!U%-HH =13:
M* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '
M44VB@!U%-HH =37^[12CGB@"M>VJW:*K '%20QB!%C P*;\XF]JL,,E6]* "
MBFT4 .HIM% #J*;10 ZBFT4 .HIM% #J*;10 ZBFT4 .J.;F%Q_LTZD;I@]^
M* .!^*U__9_@>3G!E4I^E?.W@R%KSQ+IB')_TD&O:OCW<[?#UA;*>6N "/;!
MK@?AEI:R^,K= O\ JE$A_.@#Z/B'D-;QC^Z!5J;B0-Z<TQH]TR-V%22?/$Y'
MIB@ CF#Y/I7%?$'Q"NF:8F&PS$CK75(?LUE++)Q@$U\]>/=:FUG5Q9PMN5).
ME $GA6T?Q%KWFL"1NKZ#TNS%E:+$!C K@/A;X=^Q6?VB5,,1D'%>D!LS,.P%
M $E%-HH =13:* '44VB@!U%-HH =13:* '5'.VR+/O3JAN\FW/U% $H&]D?V
MK \6:E_96@7UP3C(VC\16\IV1*#7GWQAO%MO"R0@X:6X3\LT >;^'+1M9\6Z
M7">=RF9OJ#7T5&NU<"O$?AE9M+XON[E1^[M5,:GTR*]L@),"$]2* ):*;10
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M=IY/A^74"/FO'!_I7IB)M15]!7)^#K/^S?#>F6+##"/<:ZU6W#- !BC%+10
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M'I40(=R_9!4RG<H;UH ,48I:* $Q1BEHH 3%&*6B@!,4_M3:4&@!I%&*DIE
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M=SEN!ZU>^'_AF75C&U_&593NY%>N:[HD.IS1LZ!L'N*MZ?I<-A(6C0*-H'%
M%E(O)"Q*/E"@5*(@HQ3U(;)]*13N&: %Z#%-V\@^E.HH C\D>=YO>I.V***
M$QSFEHHH **** "@]**8Q[4  ;FD=^0!2"A$S(6- "NVUU'K4'FE%N)'X$><
M?2IV3=+N]*Y?QOX@CT;P[=R@C<V8\?44 >4>)]1F\3>+_L0RULK;2?QKV?PO
MHL6CZ/##&,?**\<^&]M_:%Y/-(,L7,@8U[S:_P#'I%_NT /6,*K+_>IRC:H7
MTI:* "BBB@ HHHH **** "BBB@ S1110 4444 %%%% !1110 4444 %%%% !
M3'C$A!/:GT4 ,,8:,H>F,5XIX_\ "\FF:B^IV49,AZX%>W'H35"[M8=1MF21
M V?44 ?*NFR2Q:K)=W>4=\@YJZUQ#;2;XI.?K7HGB?X;27=UNMQM!/:LU/A!
M=Y!9S0!S4?B&Z(4H22O(I+/5=:UG6!')&^QS@UWEK\,)+9=S'.WFNOT#PE!;
M.LQB7/TH J>&_A[9V31WY4>:PR:[K[,GE"/ P*G4!4"KT I* (VA#(JGHIS3
MV&Y<4M% "*-HQ2YHHH 0#!I:** "BBB@ HHHH *:5R<TZB@ S1FBB@!I7+;J
M=110 4444 (W*XJM=DQ1,Z]5QBK+=*@NUW6[CZ4 >&_$2V$/CUKL?>=?_9:]
M)^&['_A K'W+_P#H1K@_BBGE>)()#_$I_E7<_#-]W@#3SZE__0C0!V.P K[4
M^@CD44 %%%% !1110 4444 %%%% !42L2K'TJ0]#]*9&/W;4 "/NB)[@5%!/
MVD."3Q3T_=Q.Q["LG5+A([8W>\+Y2[\9]* -.\O[>RCWS.%4>M97_"6:9(&6
M*X4L!ZUY;X@\8-X@MIX(G*%<KD&N0T72[^&>2>2Y?:0>IH ^@K;Q-87#B))E
M,@ZC-;/G)A7S\K#(-?,VG7-SINMW%R\[&-E('/O7J?A#QDOB0_82VTVZ?>/?
M% 'I&<\CIBH]S;\=J9;S!H<==HQFIXB&% "[@>!UI:B5"L['L14M !1110 4
M444 %%%% !1110 4444 %%%% #:*7%&* $HI<48H 2BEQ1B@!**7%&* $HI<
M48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**
M7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2
MBEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $ILF2 !Z\T_%(2%(SW- #92
M!"R=R*\*\?:/J*ZB)8E.QGQ7NLB9E5NU4-7TN'4XD4JN5;- 'SYIWAF]O+J/
MS$)Y]*]U\,:'%IFG+A<.5P:FL="AMW#!5X/I6PK -L'84 1;&!XJ8 @4\8I"
M0>!0 VBEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2D=PB9/K3
ML56OLBWX_O"@#S_XP7JV_A9[<'$DTJ$#VS7'?""S:X\57$[#*P?+^8K4^,DA
MGUK2K,'Y60LWX5K_  DT\6D>J71'$D@*G\* /1X@?M,K'L>*F7U]::A C9_[
MU/7E%^E !1QNYI<4TKS^% !)*,8'6J\[,SJB^E2)%N<GWIEP\=NCSLP&Q3UH
M R?$.MP:3IDB.P$C1G'UKR'PQ97'B'7+B2X!9/-.,^F:/&>N3ZWK\=K%N*!@
MO'UKT[P;X>32[:.4J,N@)H W=&TZ/3HO+1<#%:"\;OK2IAG+#MQ2+SN^M "T
M4N*,4 )12XHQ0 E%+BC% "4DC84&G8ICKNP* (IBQ*D5+,6\D;>N*?L&T#TH
M !6@""U#A3NJ51@8I9&$>/>G=: &T4N*,4 )12XHQ0 E%+BC% "44N*,4 )1
MMR:7%/7I0 PK@4TR+&O/>EF?:M9LDAEG5!TH N7%TEK9M.YP *^?/&^O2:UK
MKV43[K<MM(_VNU>K_$/51IV@-&K?,17D/@31)-;U>22521YGG9/M0!Z'X'T)
M]*TF(,F)V89_W:]+0!8U Z 5EVD8(23;C:-N*UE'R"@ HI<48H 2BEQ1B@!*
M*7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H
M2BEQ1B@!**7%&* $J.1"BC94IX!/I44,Q?[PH CPI \S[U$OF8^6I9(1(P(/
M2I\#% &5B<\$<&KJ8AM\>U3_ "^U,>/S!0!#;,S;B:FH51$F*7% "44N*,4
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M:Z/'EG/:O"/!&O-HTXC+'9*=WT)KW&RN5OK-)%(.X9H M$@C<*;0J[4Q2XH
M2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<44 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M%.C.JA>QS4M% #3S"?4"J\,<@9B3P:LXP"/6E!Q0!$JLM,AB<3,QZ$58ZT9Q
M0 U@:1%(8YI^:,YH **** "BBB@ HHHH **** "BBB@ HHHH *KWG^HY_O"K
M%12@.RH>_- 'AWQ)O%G\5,QY^S1LOYBO0OA^BGP)83H,-,,L?7FO*_B+QXQF
MC3D3/AJ]E\*68LO"^G6J#Y42@#:E!5$05.O"X]*1PN5+'I4)F_TP ?<VY- %
MFCC%)N7:&SP:K+([2L/X<T 3B10KMZ<UY;X\\;Q644NGH_[V0\8-=3XL\1VN
MDZ;<1I*!<%3A<\UYEX8\-/XPD>_U-2'67"9[B@#6\">&GO@NH7";MQR"17KJ
M1A;8(G&T8JKI6FQ:3IZVT0&U15Z/@'W- $4!,2[6ZDU,!^M(R!B#Z4Z@ HHH
MH **** "BBB@ H!&<44F.<T (26R!3<E%&?6G@;30PW\&@".X0N%Q4@X%+VQ
M10 4444 %%%% !1110 4444 %*#Q24W^/'K0!4OI=JGFHK0 LLA],U7UMS&R
M!>_6J>JZDNEZ()BV#LXH \M^)NOBY\0QZ:K9RVW%=_X!T!-.TP.4Q))R#CM7
ME.C6'_"5^-_M4@W!7SFOHBVMUMH(XU'"+B@"(Q>4S =".*LQ B)0>H%*RA\9
M[4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@!#T-1*5=#LZU,>1BF1QB,<4 $091\U/#;AQ1G(Q2!=M $+H^[(-3
MIPF31FCMB@")R9&&.U2TU5VFG4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444  ZTG\#?2E--/$1- 'BOQ=N?(O_#<W8>?_ "KK/A%>B7P+
M8+GG<_\ Z$:R_BSI$=S86DI'-N&*_C5KX.Q*G@N%3]Z(MD?4F@#T@#]XQIU5
M;:1I(XV/\6<U:H **** "BBB@ HI"<"ER,4 %%,D.$W#UIK2?O%Q]TB@![C(
M'UK@O'7B%;+,(;!(QUKH_$NIG3M-:1#\XY_"O#_$.J/KPD:,[I5/04 <U<^=
MK/B$1)DD\C\Z]W\&>%(+32(IKJ(&X&"&(KF_ /@N)[./4KE,3# Y%>M01A;=
M4'11B@"!<X5/]K/X4^7F4!:E$8$F?:EV#?NH J7R-(T*+V8%OI6/XJTN/4](
MDA"9PIQ]:Z,J"Q?VQ4*1B0,IZ4 ?,=[YEC<_8AD312[L_P"S7LWP_P!9\^T6
M*1\D#%<S\1?"J6N[4[9<RLV&QZ5R7A?Q#+93%(V^93@B@#Z-697E*#L,U)7.
M>']4COX597!FV_,*Z RH'"$_,>U #Z*CC+&0@]*EP* $HH[T#% !12C!I=M
M#:*4C%)0 4444 %%%% !13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13
M:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:*
M'44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44
MVB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@
M!U0RH2X<=ABI*&8!,GIF@#YX\:_-XUDW?PS**]VT0A-'MACH@KPWQR OCJ11
M_%<+C]*]VTX+%IT*M_=% $\B-,,@U%Y1B@DR?F/2K<1&.*K2;S>*#_J]IS0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWTJ4* *:.]  .!BD5=N?>G44 (/EI1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1FBB@"&2W$LBN>U2@;23ZTM% #
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M4N*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0
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MBEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&*
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-P3(/3O3J,XH
M:RX^[35?>YQVZU)FF(@0L?[U "%8V/(H554' IVSG-+B@!H< T_.:9LYS3@,
M4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:* '44VB@!U%-HH =13:*
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MBC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M%
M"8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+1
M0 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2
MT4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,
M4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )B
MC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "
M8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 UERN*<B[5YHILC<8% #CM)
MQ3N *JH'$@8]*G.2*  L"V*,5$J,)<GI4U "8HQ2T4 )BC%+10 F*,4M% "8
MHQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10
MF*,4M% "8HQ2T4 )BBEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ INWFG44 ';%&<44
M4 &<T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 W-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&*
M $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1
MFEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1
MB@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,
MT9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<
M48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H
M3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:
M7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&*
M $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1
MFEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1
MB@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,
MT9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<
M48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H
M3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:
M7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&*
M $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-%+BB@!:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img1.jpg
<TEXT>
begin 644 img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  0 !0# 2(  A$! Q$!_\0
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;IX8W(!9$D+J&(R0 :*Z"BG)IMM*Q$4TK,__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
